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1.1 The advancement of the high throughput screening technologies 
Over the years the need of more high throughput investigations in the molecular biology has 
increased steadily. However, the time needed to produce sufficient amount of results by 
classical means, preparing and testing sample after sample at a time has risen proportionally 
with the number of samples. Thus the efficiency of many high-throughput investigations is 
falling. The first steps in improving the efficiency of high-throughput investigation was small 
scale parallelization using microtiterplates and multi-channel pipettes. However the larger the 
number of samples, the higher are the chances of human error in the pipetting process. So 
for the further improvement of the efficiency the use of robots was introduced. This 
eliminates the chances of miss-pipetting and increases the rate of parallelization. However, 
there is the possibility to further increase the number of parallel processed samples by 
introducing miniaturization. This has been successfully applied in the field of DNA 
sequencing (next generation sequencing). Another platform for miniaturizing experiments are 
microfluidic chip systems in a glass slide format (Figure 1-1). This is similar to the 
advancement in semiconductor technology where it all started with large vacuum tubes and 
is at the stage of nano-meterscale integrated circuits today. 
 
Figure 1-1: An example of a microfluidic lab-on-a-chip system from Agilent Technology. 
Picture taken from www.agilent.com 
In order to be able to analyze or process even more samples, nanofluidic systems should be 
further adapted to fit scientific needs. For this purpose some technical problems have to be 
solved. One of those is the transfer of the sample from one chamber to another, since 
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reduction of the channels size is limited. Even in microfluidic systems the samples can not 
run under pressure or electrophoretically through channels smaller than 100 µm due to the 
viscosity. A brief look how nature solves this problem. In neuronal cells vesicles are 
continuously being actively transported from the soma to the axon terminal through axons of 
~1 µm diameter. Hence the transportation system of the axons, where the motor protein 
kinesin tows cargo along microtubule tracks, can be applied in microfluidic and nanofluidic 
systems (Hess et al. 2004). Initial investigations exploring this application have already been 
done (Nitta and Hess 2005). But the use of this transportation system is initially not that 
flexible in regard of the working conditions since it has evolved under physiological 
conditions. The microtubules can be easily polymerized in vitro (Lee et al. 1974) and kept 
stable at ambient temperatures using taxol (Wilson et al. 1985). The kinesin on the other 
hand is more susceptible to different conditions, but it is also very diverse. So, for each 
application a compatible kinesin has to be chosen from the known different kinesins present 
in different organisms. To make the process of finding the compatible kinesin easier, it might 
be possible in the future to apply phage display to produce a kinesin library by in vitro 
evolution and select under the application defined conditions. 
1.2 Kinesin 
1.2.1 Diversity 
Kinesin was first identified as a motor protein moving along microtubules after purification 
from a giant squid axon (Vale et al. 1985). This specific kinesin is being also referred to as 
conventional kinesin. Physiologically, it is a tetramer (Figure 1-2, A). A homodimer of two 
heavy chains which form the mechanochemical unit. To each of the heavy chain’s C-terminal 
domains a single light chain is associated (DeBoer et al. 2008). While the heavy chains 
possess mechanochemical and dimerization function, the light chains are responsible for 
recognition of the specific cargo within the cell, such as mitochondria (Khodjakov et al. 1998) 
or the Golgi apparatus (Gyoeva et al. 2000). Apart from the kinesin I family, other subfamilies 
of kinesins have been discovered. The kinesin-2 family is for example built either out of 
heterodimeric heavy chains and a single light chain (Figure 1-2, B) or present only as a 
heavy chain homodimer. Another kinesin family is the Unc104/KIF1 (kinesin-3) which is 




Figure 1-2: Structural depictions of the first three different subfamilies of kinesins. Picture 
adapted from http:cell.com/cgi/content/full/112/4/467/DC1 (Vale 2003). Gray: stalk, 
coiled coil; Blue: motor domain; Violet: C-terminal non-motor domains; Green: 
kinesin light chains. 
Structurally, all kinesins have a C-terminal tail responsible for cargo recognition. Different 
isoforms of the kinesin tail defines its cargo specificity. The repertoire of cargos can be 
broadened by alternative splicing, where different splice variant bind different cargos. In other 
kinesin families, such as kinesin-1 and 2, the light chains associated to the heavy chain’s C-
terminal domains specify the cargo selectivity. This rather variable part of the protein among 
the kinesin superfamily has also a secondary function, which is the autoinhibition of the 
motor domain (Verhey and Hammond 2009). Depending on the overall structure variability, 
currently 14 kinesin subfamilies are known (Figure 1-3). Although most of the subfamilies 
have different light chain and heavy chain C-terminal domains there are also subfamilies with 
more radical structural differences. Such is the kinesin-14 subfamily including the Drosophila 
Ncd where the motor domain is on the C-terminus and it moves along microtubules in the 
opposite direction than most kinesins. Another one is the mitotic spindle associated bimC 





Figure 1-3: Schematic representations of all 14 kinesin subfamilies. Picture taken from 
http://www.nature.com/nrm/journal/v10/n11/box/nrm2782_BX1.html. The motor 
domains are in light green, the coiled coils in dark green and the non-motor 
domains are in blue; KHC: kinesin heavy chain; KLC: kinesin light chain 
1.2.2 Heavy chain structure and function 
In contrast to the diverse light chains and C-terminal domains of the heavy chains of certain 
kinesin subfamilies, the principle structure and function of the remainder heavy chain is 
relatively uniform. Thus the heavy chains contain a globular motor domain most often close 
to their N-terminus, a ~13-amino acid-long neck linker and a C-terminal stalk (Figure 1-4). 
The stalk region carries the dimerization function by forming a coiled coil with the stalk of 





Figure 1-4: A crystal structure of a kinesin-1 heavy chain homodimer. Picture taken from 
http://www.stanford.edu/group/blocklab/kinesin.html. The different secondary 
structures are designated with different colours  
The stalk is connected to the motor domain through the neck linker. The neck linker does not 
have a characteristic secondary structure, but it plays a key role in the mechanism of 
movement. The remainder of the motor domain, contains a P-loop for binding ATP, two 
switches (I and II) and a large β-sheet near the core of the motor domain where the neck 
linker is docking (Marx et al. 2008). There are however some loops in the motor domain, 





Figure 1-5: An overlay of crystal structures of Neurospora crassa kinesin-3 (red-yelow), α 
(green) and β tubulin (blue) with a cryo-EM image of kinesin decorated microtubule 
where the kinesins interaction with the microtubule is locked through AMPPNP, a 
non-hydrolysable ATP analog. Figure taken from Marx et al. 2008 ; A: End-on view 
of the microtubule-motor complex with the minus end oriented to the observer; B: 
Slightly tilted sideview of the motor-dimer complex with the microtubule plus end at 
the top 
1.2.3 Mechanism of movement 
In general, kinesins are motor proteins which move along microtubules. The microtubules are 
polar, long, tube-like polymers build out of αβ tubulin heterodimers. Most kinesins move 
towards the plus- or growing end of the microtubules. There are however, as mentioned 
above, some kinesins which are minus-end orientated. The energy needed for the movement 
is gained through the hydrolyzation of ATP to ADP. Depending on the type and structure, 
kinesins can move processively, when both motor domains from the heavy chain dimer 
contribute to the movement, or non-processively when the kinesin is either monomeric, or is 
a heterodimer. In such as case, one of the motor domains does not contribute actively to the 
movement. The majority of non-processive kinesins move at a slower pace when compared 
to processive kinesins. Kinesin 3, is mostly found in its monomeric form, but can transform 
itself in a processive kinesin after dimerization (Hammond et al. 2009). 
During the process of movement one of the motor domains of processive kinesin strongly 
interacts with the microtubule and throws the other, trailing motor domain forwards. This 
motor domain than undergoes a stronger bond with the microtubule and takes its turn to 
throws the now loosely bound motor domain forwards. Since each motor domain can only 
interact at a specific site of a single αβ tubulin heterodimer, one step of a kinesin is exactly as 
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long as the length of the αβ tubulin heterodimer, that is 8 nm. However, the most interesting 
characteristic about the movement of kinesins is that they always move in one direction, 
implying the presence of a gating mechanism. In a recent single molecule study this 
mechanochemical gating mechanism was well described (Guydosh and Block 2009). It was 
shown that in the absence of a nucleotide in the ATP binding pocket of the leading motor 
domain, it binds intermediately tight to the microtubule, whereas the trailing motor domain 
containing ADP is just loosely bound. Upon entrance of ATP in the binding pocket the 
leading motor binds tightly and the trailing motor domain is being thrown to the front. During 
this movement the ATP in the now trailing motor domain is being hydrolyzed. At the same 
time in the now leading motor domain the ATP binding pocket releases the ADP and is ready 
to accept ATP. With this, the cycle is closed and can be repeated (Figure 1-6). During its 
microtubule-bound state, the ATP-binding domains of the kinesin heads can only be fitted 
with the described combination of ADP or ATP due to mechanistic reasons. This gating 
mechanism confirms the one-head-bound mode of movement. 
 
Figure 1-6: A schematic model of the mechanochemical gating mechanism of the processive 
kinesin movement along microtubules. Firgure taken form: Guydosh and Block 
2009; S1-S3 are the hypothetical states at which the kinesin can not be found in, 
which contributes to the rigid gating of the state conversionts 
The unique processive movement mechanism of dimeric kinesins is not defined only by the 
mechanochemical gating system, but also by other mechanistic properties. Recently, it has 
been additionally shown that the length of the neck linkers as well as their attachment points 
are crucial for the processive movement (Miyazono et al. 2009). The neck linker is the part of 
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the motor domain which changes position upon ATP induced conformational change. In this 
process, the neck linker moves from the undocked position towards the motor domain core-
β-sheet where it docks, thus producing a power-stroke (A, Figure 1-7). Since the neck linker 
acts as a lever, its full length is vital for the movement (B, Figure 1-7). The length of the neck 
linkers is equally adapted to the length of a single kinesin step. This way the forward thrown 
motor domain falls as close as possible to the binding site, and needs less time to find its 
position by diffusion. An engineered alternative binding of the neck linker from the one 
monomer to the N-terminus of the other monomer shows processive movement but not 
comparable with natural one. This suggests that the N-terminus might be involved in the 
conformational changes associated with the powerstroke. 
 
Figure 1-7: A: Relative position of the neck linker to the whole motor domain in a docked and 
undocked state; B: hypothetical difference in the bias depending from the neck 
linkers length; The + and the – represent the relative orientation of the motor 
domains to the orientation of the microtubule. Figure taken from Miyazono et al. 
2009 
1.3 in vitro application of the kinesin-microtubule system 
Ever since it is possible to polymerize microtubules in vitro, it has also been possible to 
observe the movement of kinesin along these microtubules. In this process the presence of 
taxol is important as it stabilizes microtubules and preserves ATP for the kinesin to utilize as 
a source of energy. A number of different set-ups exist to visualize kinesis moving along 
microtubules. One of the simplest ways is to functionalize a glass slide or a coverslip with 
kinesins and to add microtubules (B, Figure 1-8). this case the kinesins are moving the 
microtubules, and this process can be visualized using video enhanced differential 
interference contrast microscopy (Schnapp et al. 1988),  (Schnapp et al. 1988), or using a 
fluorescence microscope in case the microtubules are fluorescently labeled. This way of 
observing the movement of the kinesin along microtubules is better known as gliding assay, 
since the microtubules look like they are gliding over the surface. In this mode of the kinesin-
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microtubule transportation systems different microtubules move in different directions. 
Alternatively, the gliding movement of the microtubules can be used in a micro or nanofluidic 
system, where the channels are wide enough for a microtubule to enter, but narrow enough 
so that it can not turn around or get stuck in a perpendicular orientation. Under these 
conditions the microtubules can be transported along kinesin coated channels. Once they 
enter the channel they can move only in one direction and act as a shuttle (Carroll-Portillo et 
al. 2009). Another possibility to observe the kinesin movement is where microtubules are 
immobilized onto a surface and the kinesin moves along the microtubules, just as it occurs in 
the nature (A, Figure 1-8). For the observation of a single molecule, kinesins are either 
fluorescently labeled or they can be conjugated to small beads (bead assay). In this case the 
transportation system can be more precisely engineered than in the first case. Carefully 
adjusting the orientation of microtubules, kinesins can move in a given direction. This way 
the cargo is transported much faster than by a microtubule shuttle which depends on the 
diffused motion of the microtubules on the kinesin coated surface. 
 
Figure 1-8: Cartoons which shows the concept of a bead assay (A) and a gliding assay (B). 
Picture taken from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=mcb& 
part=A5452  
1.4 Phage display 
One Among others, phage display is a very interesting tool used in molecular biology to 
mimic evolutionary processes. The method is based on presenting proteins or peptides of 
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interest on the surface of filamentous bacteriophages by genetically fusing the gene of 
interest to a gene encoding one of the coat proteins of the phage (Smith 1985). Once phage 
particles are produced by an infected host, the recombinant fusion protein is expressed from 
the phage genome and integrated into the phage virion during the assembly process of the 
particle, which harbors’ the DNA. Thereby the phenotype is directly coupled with its genotype. 
The most common phage display system is base on the bacteriophage M13, which is 
filamenous, non-lytic and contains a circular ssDNA. The DNA is enclosed by a rod shape 
cylinder assembled from ~2700 copies of protein pVIII. At the proximal, or infectious tip of the 
phage five copies each of protein pIII and pVI are presented. On the other end, the so-called 
remote tip, five copies each of proteins pVII and pIX are present (Figure 1-9). Although there 
are cases where the phage coat protein  pIX was fused with peptides, the most successful 
presentation on the phage is done by fusing the protein of interest to the N-terminus of the 
phage coat protein pIII. 
 
Figure 1-9: Schematic presentation of the M13 filamentous phage; pIII, pVI, pVII, pVIII and pIX 
are the different proteins found on the phage 
For production of protein-presenting phages, an E. coli strain containing the F-episome is 
transformed with an engineered phagemid – essentially a plasmid containing the gene of 
interest fused to gIII, the M13 origin of replication and packaging signal and a selective 
marker gene. Next, the bacterial cells are infected with a M13 helper phages. Helper phages 
contain all genes necessary for the assembly of fully infectious bacteriophage particles, but 
have an impaired packaging signal. During the assembly process all proteins necessary for 
the capsid formation are expressed and phage particles start assembling at specifically 
organized pore complexes at the inner membrane of E. coli. Proliferation of a single phage 
begins with the remote tip and as the capsid is elongated to cover the DNA, it protrudes 
through the outer membrane into the surrounding milieu. Finally the proximal tip is 
assembled and the phage is released (Figure 1-10). For efficient incorporation of the pIII 
protein into the capsid, it has to be transported to the periplasm of the bacteria where it 




Figure 1-10: Schematic representation of a M13 bacteriophage assembly. Image taken from B. 
K. Kay, J. Winter, J. McCafferty; “Phage Display of Peptides and Proteins”; 
Academic press, Harcourt Brace & Co.; OM: outer membrane; IM: inner 
membrane. pIII-pIX: M13 bacteriophage associated proteins; trx: thioredoxin 
Transportation of pIII into the periplasm depends on the leader sequence. Most commonly 
used leader sequence for phage display is pelB, which is recognized in the Sec-dependent 
pathway. In this secretory pathway the proteins are being translocated post-translationally 
through the cytoplasmic membrane in the periplasm in an unfolded state (Nilsson et al. 1991). 
It has been shown however that pIII fusion proteins can be successfully translocated to the 
periplasm and incorporated into phages using another, so-called signal recognition particle 
(SRP) pathway (Thie et al. 2008). This translocation pathway uses different leader 
sequences and the translocation of the polypeptide is being performed co-translationally 
(Valent 2001). Additionally, the twin arginine translocation (Tat)-mediated pathway is also 
present in E. coli, whereby proteins are translocated across the cytoplasmic membrane in an 
already folded fashion. Since pIII can only fold properly in the periplasm and not in the 
cytoplasm, this translocation pathway is not applicable for its transport to the periplasm. This 
excludes the possibility to present proteins which need to be folded in the cytoplasm to 
function properly, for example GFP (Feilmeier et al. 2000). from being presented on the 
phage surface as a pIII fusion protein. Short peptides where first to be presented on the 
phage surface using this method (Devlin et al. 1990) in the hope to produce combinatorial 
library for selection of specific binder peptides. Shortly after that, the first antibody fragment 
libraries utilizing phage display were generated (Clackson et al. 1991; McCafferty et al. 1991). 
Notably, for ~10 years, phage display was the only way of selecting fully human antibodies 
breaking ground for the development of human therapeutic antibodies. Apart from producing 
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specific binders, functionally active enzymes have also been successfully presented on M13 
phage particles (Corey et al. 1993; McCafferty et al. 1991).  
1.5 Protein engineering and goal 
the development of nanobiotechnology and lab-on-a-chip technologies there is growing need 
not only for simple tools, but rather for tunable tools. In this respect, a more robust and 
tunable kinesin-microtubule transportation system would be of great interest and would 
surely find a much broader use in future lab-on-a-chip applications than the natural systems 
currently under investigation. Bearing said in mind, the most important criteria for selecting a 
kinesin molecule to investigate, is its robustness and thermostability. There are many 
eukaryotic organisms whose optimal living temperature is higher than usual ambient 
temperatures. These are good candidates for obtaining a kinesin that is stable at higher 
temperatures. In this respect the fungus Thermomyces lanuginosus whose growth optimum 
is at 50° was the organism of choice for fulfilling the first criteria. Other enzymes form T. 
lanuginosus have already been used before, explicitly due to their thermostable property 
(Basaveswara Rao et al. 1981; Damaso et al. 2003; Guo et al. 2005; Li et al. 2005; Rezessy-
Szabo et al. 2007). Two ortholog of the kinesin-3 family from T. lanuginosus, the TLKIF1 and 
TKIN had been previously cloned, expressed in E. coli and functionally characterised (Rivera 
et al. 2007; Sakowicz et al. 1999) Since TKIN was characterized more recently and in greater 
detail, TKIN was taken as the basis for this investigation,  The speed of this kinesin in a 
microtubule gliding motility assay has been reported to be up to 5,5 µm/s, which is 
considerably faster than the conventional kinesin-1 family representatives from the animal 
kingdom. The basic sequence of TKIN has been modified to match further criteria. First the 
coiled coil 2 (CC2) domain and the forkhead associated (FHA) domain (Figure 1-2) have 
been removed. The coiled coil 1 (CC1) domain has been kept in order to test if the normally 
monomeric TKIN can form dimers using only the CC1 domain, thus producing processive 
movement after dimerization. In a second step all cysteins and a serine residue were 
exchanged with other amino acids. This was necessary as free cysteins can be crosslinked 
in an oxidative environment, such as the periplasm or simply atmospheric conditions. Next, 
the sequence was optimization for prokaryotic expression by exchanging base triplets with 
analogous triplets encoding the same amino acid, but corresponding to a more abundant 
tRNA in E. coli. Codon optimization shall allow higher yield of the recombinant proteins as no 
limitations of tRNAs should be encountered. Thanks to technological progress, the 
modifications described above were not needed to be introduced one by one. The whole 
coding sequence of the modified TKIN (mTKIN) including respective cloning site added to 
each end of the sequence was synthetically ordered from the gene synthesis company 
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Sloning BioTechnology (Puchheim). Once the construct has arrived, it was cloned behind a 
lac promotor sequence of the pQDKG2 vector (AG Konthur, MPI for Molecular Genetics, 
Berlin) which is a pQE30 derivative (QIAGEN). This enables the controlled expression of the 
protein by adding IPTG to the medium to induce protein expression. Additional features of 
this vector includes a C_terminal Avi-His6-tag. This is a bi-functional tag where the first part 
consists of a synthetic minimal recognition motif (Figure 1-11) This motif is recognized in E. 
coli by the endogenous enzyme biotin ligase (birA) which post-translationally modifies the 
lysine residue of the tag by addition of a biotin. The second part of the tag contains six 
histidines. Once expressed, the recombinant protein is automatically biotinylated and can be 
easily immobilized onto streptavidin coated surfaces by exploiting the specific and highly 
stable biotin-streptavidin interaction. The His6-tag is important for Ni-NTA affinity purification 
purposes since this purification method is relatively inexpensive and common for 
recombinant protein purification. 
 
Figure 1-11: structural representation of the Avi-tag amino acid sequence which has been 
biotinylated. Image taken from http://www.fulengen.com/images/AviTag.gif  
For the periplasmic expression and phage display the mTKIN sequence was cloned into the 
phagemid vector pIT2. mTKIN is introduced in between the pelB leader sequence for 
translocation into the periplasm and the M13 gene III. The resulting construct expresses 
mTKIN either with a C-terminal His6-tag only, or as a fusion-protein to pIII, depending on the 
host strain used. The project pursues three main goal. Primarily, the best expression 
conditions for mTKIN using the pQDKG2 vector shall be establishing and an affinity 
chromatography based purification scheme shall be developed. Second goal was to assess 
the periplasmic expression and presentation efficiency of mTKIN on filamentous M13 
bacteriophages using the pIT2 vector. Last,  the biochemical and mechanochemical 
properties of mTKIN expressed in E. coli and presented on M13 phages shall be investigated. 
The project pursues three main goal. Primarily, the best expression conditions for mTKIN 
using the pQDKG2 vector shall be establishing and an affinity chromatography based 
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purification scheme shall be developed. Second goal was to assess the periplasmic 
expression and presentation efficiency of mTKIN on filamentous M13 bacteriophages using 
the pIT2 vector. Last, the biochemical and mechanochemical properties of mTKIN expressed 
in E. coli and presented on M13 phages shall be investigated. 
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2.1 Materials for E. coli and phage work 
2.1.1 E. coli strains 
 
Strain name Genotype Source 
DH10 B F- mcrA Δ(mrr-hsd RMS-mcrBC) 
Φ80dlacZΔM15 ΔlacX74 endA1 recA1 
deoR Δ(ara, leu)7697 araD139 galU 
galK nupG rpsL λ-
Invitrogen, Carlsbad, USA 
BL21 (DE3) star 
pRARE3 
F- ompT hsdSB (rB B- mB-) gal dcm rne131 
(DE3) [pRARE3, lacI , birA, Cm ] q r
MPI for Molecular Genetics 
BL21 (DE3) pLysS F–, ompT, hsdSB (rB B–, mB–), dcm, gal, 




F– ompT hsdS (rB– mB–) dcm+ Tetr gal 
λ(DE3) endA Hte [argU ileY leuW Camr] 
Stratagene, La Jolla, USA 
Origami™ B (DE3) 
pLacI 
F– ompT hsdSB (rB B– mB–) gal dcm lacY1 
ahpC (DE3) gor522::Tn10 trxB [pLacI 
(Cam , Kan , Tet )] R R R
Merck, Darmstadt 
TG 1 supE thi-1 Δ(lac-proAB) Δ(mcrB-
hsdSM)5(rK– mK–) [F’ traD36 proAB 
lacIqZΔM15] 
Stratagene, La Jolla, USA 
XL-1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac [F’ proAB lacIqZΔM15 
Tn10 (Tetr)] 
Stratagene, La Jolla, USA 
HB2151 nalr thi-1ara ∆(lac-proAB) thi [F’ pro A+B 
lacIq lacZ∆M15] 
Clontech, Mountain View 
USA 




M13KO7 Helper Phage (N0315S) New England Biolabs, Frankfurt am Main 
Hyperphage (PRHYPE) Progen, Heidelberg 
2.1.3 Culture medium 
Liquid 
2xYT (per 1 L): LB (per 1 L) 
16 g Bacto Tryptone 
10 g Bacto Yeast Extract 
5 g NaCl 
pH 7,2 with NaOH 
ad H2O up to 1 L 
autoclaved 
10 g Bacto Tryptone 
5 g Bacto Yeast Extract 
10 g NaCl 
pH 7,5 with NaOH 
ad H2O up to 1 L 
autoclaved 
Agar medium  
2xYT Agar (per 1 L) LB Agar (per 1L) 
16 g Bacto Tryptone 
10 g Bacto Yeast Extract 
5 g NaCl 
pH 7,2 with NaOH 
15 g agarose 
ad H2O up to 1 L 
autoclaved 
10 g Bacto Tryptone 
5 g Bacto Yeast Extract 
10 g NaCl 
pH 7,5 with NaOH 
15 g agarose 
ad H2O up to 1 L 
autoclaved 
Top-agar (per 1 L) M9 Minimal agar medium (per 1 L) 
7 g agarose 
in H2O 
200 mL 5x M9 salts 
2 mL 1M MgSO4 
20 mL 20% Glucose 
0.1 mL CaCl2 
15 g agarose 
in H2O 
Glucose was usually added to the medium to a total concentration of 2%except otherwise 
designated. For selective growth purposes the following antibiotics were added to the final 
concentrations of: 
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Antibiotic (final work concentration in meduim) Manufacturer 
Ampicillin (100 μg/mL) Carl Roth, Karlsruhe 
Kanamycin (60 μg/mL) Roche, Basel 
Chloramphenicol (17 μg/mL) Roche, Basel 
Tetracyclin (10 μg/mL) Roche, Basel 
 
2.2 Prefabricated materials 
2.2.1 Kits 
Product Manufacturer 
peqGOLD Plasmid Miniprep Kit I (12-6942-02) peqlab Biotechnologie, Erlangen 
QIAGEN® Plasmid Maxi Kit (12163) Qiagen, Hilden 
ATP Affinity Test Kit (AK-102) Jena Bioscience, Jena 
CN/DAB Substrate Kit (34000) Thermo Scientific, Bonn 
EasyXpress Insect Kit II (32561) Qiagen, Hilden 
RNeasy MinElute Cleanup Kit (74204) Qiagen, Hilden 
2.2.2 Other prefabricated materials 
Product Manufacturer 
10X NEB buffer EcoRI (B0101S) New England BioLabs, Frankfurt am Main 
10x HF PCR buffer (K0192) Fermentas, St. Leon-Rot 
GeneRuler™ 100 bp Plus DNA Ladder 
(SM0321) 
Fermentas, St. Leon-Rot 
GeneRuler™ 1 kb DNA Ladder 
(SM0311) 
Fermentas, St. Leon-Rot 
6x Loading dye (R6011) Fermentas, St. Leon-Rot 
Complete protease inhibitor cocktail 
(04 693 124 001) 
Roche, Basel 
Ni-NTA Agarose (30230) Qiagen, Hilden 
Ni-NTA Magnetic Agarose Beads (36113) Qiagen, Hilden 
Ni-NTA SuperFlow Cartridges 1 mL (1034559) Qiagen, Hilden 
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Product Manufacturer 
NuPAGE® 4-12% Bis-Tris Gel (NP0329BOX) Invitrogen, Carlsbad 




2.3 Materials for molecular biology work 
2.3.1 Enzymes 
Enzyme Manufacturer 
EcoRI (R0101S) New England BioLabs, Frankfurt am Main 
HindIII (R0104S) New England BioLabs, Frankfurt am Main 
HF PCR enzyme mix (K0191) Fermentas, St. Leon-Rot 
Lysozime (L 6876) Sigma, Steinheim 
Pyruvate kinase/Lactic dehydrogenase from 
rabbit muscle (P0294) 
Sigma, Steinheim 
 
2.3.2 Oligonucleotides, Plasmids 
Oligonucleotide/Plasmid Producer 
pQE276 (GGCAACCGAGCGTTCTGAAC) Eurofins MWG Operon 
JD5’ (CCCGAAAAGTGCCACCTGAC) Eurofins MWG Operon 
pUC18 Stratagene, La Jola (CA) 
Synthetic mTKIN sequence Sloning BioTechnology, Puchheim 
pQDKG2/mTKIN (Figure 2-1) MPI for Molecular Genetics, cloned by 
Dr. Volker Sievert 
pIT2/mTKIN (Figure 2-2) MPI for Molecular Genetics, cloned by 
Dr. Volker Sievert 
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Figure 2-1: pQDKG2/mTKIN plasmid map generated with Vector NTI 
 
Figure 2-2: pIT2/mTKIN plasmid map generated with Vector NTI 
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2.3.3 Antibodies, detection protein conjugates and other proteins 
Proteins Manufacturer 
Streptavidin-HRP Thermo Scientific, Bonn 
Anti-His (mouse) Trend Pharma & Tech, Surrey, BC, Canada 
Anti-PIII (mouse) MoBiTec, Göttingen 
Anti-mouse-HRP (rabbit) Sigma, Steinheim 
Tubulin from bovine brain (TL238) Cytoskeleton Inc., Denver 
Tubulin X-rhodamine labeled from bovine 
brain (TL620M) 
Cytoskeleton Inc., Denver 
Recombinant KIF1A-GFP (kinesin-3, R. 
norvegicus)  
MPI for Colloids and Interfaces, 
Potsdam-Golm 
 
2.3.4 Gel compositions 
SDS-PAA stacking gel (per 80 mL): 
10.4 mL H2O 
0.8 mL 10% SDS 
20 mL 1.5 M Tris-HCl pH 8.8 
48 mL 29% Acrylamid, 0.8% bisacrylamid 
Activation of polymerization: 
800 µL 10% Ammonium persulfate 
25 µL TEMED 
SDS-PAA separating gel (per 40 mL): 
23.8 mL H2O 
0.4 mL 10% SDS 
10 mL 0.5 M Tris-HCl pH 6.8 
5.3 mL 29% Acrylamid, 0.8% bisacrylamid 
Activation of polymerization: 
400 µL 10% Ammonium persulfate 
40 µL TEMED 
 
2.4 Other compounds and solutions 
2.4.1 Compounds 
Product Manufacturer 
UltraPure™ agarose (15510-019) Invitrogen, Carlsbad 
IPTG Fermentas, St. Leon-Rot 
Phenylmethanesulfonyl fluorid –PMSF (P7626) Sigma, Steinheim 
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Product Manufacturer 
Ethidium bromide Merck, Darmstadt 
Urea (A1361) AppliChem, Darmstadt 
Polyethylene glycol 6000 Merck, Darmstadt 
dNTP’s  Invitrogen, Carlsbad, USA 
D(+)-Glucose monohydrate Merck, Darmstadt 
GTP (G8877) Sigma, Steinheim 
ATP (A3377) Sigma, Steinheim 
PEP (P7127) Sigma, Steinheim 
NADH (N8129) Sigma, Steinheim 
Taxol (A4667) AppliChem, Darmstadt  
2.4.2 Buffers and solution 
TAE: 
40 mM Tris-acetate 
1 mM EDTA 
pH 8 
Native lysis buffer (NPI-10): 
50 mM NaH2PO4 
300 mM NaCl 
10 mM Imidazole 
pH 8.0 (NaOH) 
Native wash buffer (NPI-20): 
50 mM NaH2PO4 
300 mM NaCl 
20 mM Imidazole 
pH 8.0 (NaOH) 
Native elution buffer (NPI-250): 
50 mM NaH2PO4 
300 mM NaCl 
250 mM Imidazole 
pH 8.0 (NaOH) 
Laemmli running buffer: 
0.125 mM Tris 
1.25 mM Glycine 
0.5% SDS 
Laemmli loading buffer 4x: 
0,2 M Tris-HCl pH 6,8 
8% SDS 
40% (w/v) Glycerol 
0,004% Bromophenol blue 
5% β-Mercaptoethanol 
20 x MES running buffer: 
1 M MES 
1 M Tris-base 
69,3 mM SDS 
20,5 mM EDTA 
Coomassie-stain: 
1,25 g Coomassie Brilliant Blue R- 250 
225 ml Ethanol (mixed with methanol) 
225 ml H2O 
50 ml Acetic acid 
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Destaining solution: 
10% Acetic acid 
20% Ethanol (mixed with methanol) 
in H2O 
Blotting buffer: 
3 g/L Tris-base 
14 g/L Glycine 
PTM: 
1x PBS 
2% (w/v) Blotting grade non-fat dry milk 
1% Tween® 20 
TES buffer: 
0.2 M Tris-HCl pH 8.0 




0.5 M Sucrose 
0.1 M Tris-HCl pH 8.0 
1 mM EDTA 
Phage precipitation buffer: 
20% PEG 6000 
2,5 M NaCl 
autoclaved 
10x PBS: 
2.5 g/l KCl 
80 g/l NaCl 




0.1% Tween® 20 
All of the salts and chemicals were per analysis grade and purchased from: Merck 
(Darmstadt), Sigma (Steinheim), BioRad (Munich) or Invitrogen (Carlsbad, USA) 
2.5 Laboratory equipment 
Product Manufacturer 
Pipettes, PIPETMAN® 1000, 200, 20, 2 μL Gilson, Middelton (WI) 
Multichannel pipettes 5-50 µl, 20-200 µl Abimed, Langenfeld 
PIPETBOY accu INTEGRA Biosciences, Zizers 
Centrifuge 5810R eppendorf, Hamburg 
Centrifuge 5424 eppendorf, Hamburg 
Incubator shaker innova ™ 4430 New Brunswick Scientific, New Jersey 
Incubator memmert, Schwabach 
PTC 200 Thermo Cycler MJ Research, Waltham (MA) 
NanoDrop 2000 Thermo scientific, Wilmington (DE) 
MicroPulser Electroporator Bio-Rad, Hercules (CA) 
SE 215 Mighty Small Multiple Gel Caster Hoefer, Holliston (MA) 
Materials and Methods 
 23
Product Manufacturer 
SE 250 Mighty Small II Hoefer, Holliston (MA) 
XCell SureLock™ Electrophoresis Mini-Cell Invitrogen, Carlsbad 
XCell 4 SureLock™ Electrophoresis Midi-
Cell 
Invitrogen, Carlsbad 
Electrophoresis Power Supply EPS 200, 
300, 301, 600  
Pharmacia Biotech, Freiburg 
Gel documentation GelDoc 2000 BioRad, Munich 
UV-Lamp Model UVL 21 Ultra-Violet Products, San Gabriel, USA 
Linear shaker Gerhardt, Königswinter 
22 Mighty Small™ Transphor tank transfer 
unit 
Hoefer, Holliston (MA) 
Image analyser LAS 1000 Fujifillm, Düsseldorf/ raytest, Straubenhardt 
Digital pH-/ mV-/ Thermometer Greisinger, Regenstauf 
AF 20 Flake Ice Machine Scotsman, Vernon Hills, USA 
Vortexer Vortex-Genie  Scientific Industries, New York, USA 
weighing scale Adventurer™ Pro AV812 Ohaus, Pine Brook, USA 
Biophotometer Eppendorf, Hamburg 
Magnetic stirrer MR3001 Heidolph, Schwabach 
Roller TRM-V IDL, Nidderau 
Thermomixer comfort 5355 Eppendorf, Hamburg 
Microflow Laminar Flow Workstation Kendro, Langenselbold 
Axioimager.Z1 Zeiss, Göttingen 
LSM 700 Zeiss, Göttingen 
SpectraMax, Microplate reader Molecular devices, Sunnyvale (CA) 
ÄKTApurifier GE Helthcare, Munich 
LTQ-Orbitrap Thermo Scientific, Wilmington (DE) 
2.6 Laboratory consumables 
Product Manufacturer 
Polypropylene tubes 15, 50 mL Greiner Bio-one, Frickenhausen 
Disposable tubes 0.5, 1.5, 2 mL Eppendorf, Hamburg 
Disposable flasks 250, 500 mL Corning, New York, USA 
Polypropylene tubes 14 ml Greiner Bio-One, Frickenhausen 
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Product Manufacturer 
Disposable sterile pipettes (5, 10, 25 mL) Corning, New York, USA 
Disposable pipette tips 
(10, 200, 1000 μL) 
Gilson, Middleton, USA; Greiner Bio-One, 
Frickenhausen, Eppendorf, Hamburg 
Disposable stuffed pipette tips 
(10, 200, 1000 μL) 
Biozym, Oldendorf 
Inoculation loops Nunc, Roskilde, Denmark 
96-well Flexible PVC Microplates, flat-bottom Becton, Dickinson and Company, Franklin 
Lakes, USA 
Microtiter plate NUNC-Immuno Plate F96 
Maxisorp 
Nunc, Roskilde, Danmark 
PCR-8 tube stripes Greiner Bio-One, Frickenhausen 
Petri dishes Greiner Bio-One, Frickenhausen 
Electroporation cuvettes (0,1 cm gap) Bio-Rad, Hercules (CA) 
Disposable cuvettes (P948) Carl Roth, Karlsruhe 
Amersham Hybond™ ECL™ GE Healthcare, Freiburg 
Whatman Paper 3 mm  Whatman, Maldstone, USA 
Graduated cylinder 100-1000 ml Fortuna, Brilon 
Erlenmeyer flasks 250 mL, .05 L, 1L Schott, Mainz 
Glass bottles 100 ml, 250 ml, 0.5 L, 1 L Schott, Mainz 
Spectra/Por dialysis membrane tubing 
MWCO: 3500 (132 720) 
Spectrum Laboratories, CA, USA 
Cover slips Menzel-Gläser, Braunschweig 
Microscope slides Carl Roth, Karlsruhe 
 
2.7 DNA preparation and analysis 
2.7.1 Plasmid preparation 
Glycerol stocks of the E. coli DH10B clones carrying sequence-confirmed mTKIN constructs 
were used for inoculation of 2xYT medium supplemented with ampicillin. For preparation of 
smaller plasmid amounts (miniprep) the peqGOLD Plasmid Miniprep Kit I from peqlab was 
used. The preparation was performed in accordance with the manufacturer’s protocol found 
in the kit’s handbook from 4 mL cultures. For production of larger plasmid amounts (maxiprep) 
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the Plasmid Maxi Kit from Qiagen was used. The pIT2/mTKIN construct was prepared from 
100 mL culture in accordance with the standard protocol found in the manufacturer’s 
handbook. For the maxiprep of the pQDKG2/mTKIN the protocol for low-copy plasmids was 
used and the plasmid was prepared from a 500 mL culture. This was necessary since the 
pQDKG2 is a derivative of a low-copy plasmid. Irrespective of the manufacturer, both 
plasmid preparation kits are based on purifying DNA from a soluble cell lysate over a 
disposable ion-exchange chromatography column. 
2.7.2 Analysis of plasmid preparations using DNA restriction digest 
The presence of the mTKIN gene in the vector was analyzed by restriction digest of plasmid 
DNA from the maxiprep of pQDKG2/mTKIN. Digest was carried out with single cutter 
restriction enzymes. The pQDKG2/mTKIN was digested with an aliquot of EcoRI and HindIII 
restriction enzymes (Table 2-1). The in silico digest with these enzymes should produce a 
1522 bp and a 2506 bp long DNA fragment. For a better analysis, an aliquot of a non-
digested pQDKG2/mTKIN was loaded on a gel next to the digested sample to rule out 
additional bands corresponding to non-digested plasmid DNA. The relative size of the bands 
was determined by comparison with a DNA ladder (GeneRuler™ 1 kb DNA Ladder, 
Fermentas). 
Table 2-1: Reaction mixture for a analytical Plasmid DNA restriction digestion 
Plasmid pQDKG2/mTKIN ~380 ng (0,5 µL) 
10X NEB buffer EcoRI 2 µL 
Eco RI 5 U (0,25 µL) 
Hind III 5 U (0,25 µL) 
H2O ad 20 µL 
37° C, 1 hour 
 
2.7.3 DNA gel electrophoresis 
For analysis, DNA fragments were chromatographically separated according to their size in 
an agarose gel using an electric field. The gel consists of a 1% agarose solution in TAE 
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buffer which was subsequently heated in a microwave oven in order to dissolve the agarose. 
After the gel cooled down to ~60°C, 1 µL ethidium bromide stock (stock conc. 10 mg/mL) – a 
DNA intercalating fluorescent compound – was added to each 50 mL agarose solution and 
was gently mixed. The liquid gel was than poured into a electrophoresis chamber containing 
a comb to produce sample pockets and let to solidify. Once hardened, the comb was 
removed from the gel and the chamber was filled with TAE buffer. The samples were mixed 
with 6x loading dye before loading onto the gel and the gel was run at 80 V for 40 minutes. 
After gel electrophoresis the position of the DNA fragment was detected by UV light at 254 
nm. 
2.7.4 mTKIN ORF amplification by polymerase-chain reaction 
As a prerequisite for high efficiency of the in vitro transcription step within the in vitro 
expression procedure of mTKIN (2.11) a concentrated linear form of the mTKIN ORF was 
produced. For this purpose the mTKIN ORF was PCR-amplified from the pQDKG2/mTKIN 
construct using the primers pQE276 and JD 5’. This primer pair was chosen after 
determining in silico that it bind in the flanking regions of the mTKIN ORF and include all 
necessary promoter regions needed for transcription and translation (Figure 2-1). The PCR 
was performed in 50 µL reaction volume (Table 2-2). 
Table 2-2: Reaction mixture for PCR amplification of the mTKIN ORF, used for in vitro 
expression 
 
10x HF PCR buffer 5 µL 
dNTP’s 0,2 mM each (4 µL) 
JD 5’ 10 pmol (1 µL) 
pQE276 10 pmol (1 µL) 
pQDKG/mTKIN ~90 ng (0,5 µL) 
HF PCR Enzyme Mix 2,5 U (0,5 µL) 
H2O ad 50 µL 
Total reaction volume 50 µL 
 
The PCR cycler program was set as in Table 2-3
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Table 2-3: PCR cycler program for the amplification of the mTKIN ORF 
Step Temperature Time Cycles 
Initial denaturation 95° C 5 min 1x 
Denaturation 95° C 20 sec 
Annealing 60° C 30 sec 
Elongation 72° C 2 min 
35x 
Final elongation 72° C 10 min 1x 
End 4° C ∞  
 
2.7.5 Gel purification of the PCR-amplified mTKIN ORF 
For the isolation of the PCR amplified mTKIN ORF the whole 50 µL of the PCR reaction was 
loaded on a 1% agarose gel. A small aliquot was loaded in a small pocket beside the large 
pocket where the remaining of the PCR reaction was loaded. The lane with the small aliquot 
was separated from the gel and used for better orientation of the PCR product position on 
the gel. The PCR-product band from the larger lane was cut out of the gel as fast as possible 
while illuminating it with UV light with longer wavelength (365 nm), hence minimizing the 
chance of introducing DNA damage. The DNA from the gel piece was isolated using the 
peqGOLD Gel Extraction Kit from peqlab. The isolation was performed in accordance with 
the manufacturer’s protocol. The kit’s procedure basically contains a step  where the DNA 
containing gel piece is dissolved in a special buffer and then the DNA fragment is batch 
purified using a ion exchange chromatography column. Since the purified fragment in this 
investigation was going to be used for in vitro transcription, the DNA was eluted in RNase-
free water. 
2.7.6 DNA concentration 
The concentration of all plasmid DNA or PCR products was determined using a Nanodrop 
instrument blanked with the buffer in which the DNA was eluted or diluted. The DNA 
concentration was being quantified relative to the UV absorption of the pyrimidine bases, 
under the assumption of a 1:1 ratio between the pyrimidine and the purine bases as well as 
with the respect of measuring double stranded DNA. Additionally, the 260/280nm ration 
determines the purity of the DNA from proteins. 
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2.8 Protein expression 
2.8.1 Preparation of electrocompetent E. coli cells 
For the preparation of E. coli cells suitable to be transformed with a plasmid using 
electroporation (2.8.2), a 50 ml of 2xYT medium containing the appropriate antibiotics were 
inoculated with cells from a glycerol stock of the wanted E. coli strain. This starting culture 
was incubated in an Erlenmeyer flask at 37° C and 180 rpm shaking speed. On the following 
day the starting culture was used for inoculation of 500 ml of prewarmed (37° C) 2xYT 
medium containing the appropriate antibiotics to a OD600 ~0.05-0.10. The new culture was 
grown at 37° C and 180 rpm shaking speed until the optical density at 600nm wavelength 
(OD600) reached a value between 0.3 and 0.5. At this point the culture was placed on ice for 
30 minutes, transferred to two pre-chilled 250 ml centrifugation bottles and cells were 
harvested by centrifugation at 4°C and 3220g for 15 minutes. The supernatant was discarded, 
the cells were re-suspended in 250 ml ice-cold Millipore-purified water and left on ice for 15 
minutes. Next, the cells were once more harvested by centrifugation as described before. 
The supernatant was discarded, the cells were re-suspended in 100 mL cold Millipore-
purified water per bottle, transferred to 50 mL Falcon tubes and incubated on ice for further 
15 minutes. After a repeated cell harvesting, cells from two 50 mL tubes were re-suspended 
in 25 mL ice-cold 10% glycerol (Millipore purified water) solution, transferred to a fresh 50 mL 
tube, incubated for 15 minutes on ice and harvested again as before. Finally, the cells from 
each 50 mL tube were re-suspended in 2 mL ice-cold 10% glycerol (Millipore purified water) 
and  aliquoted in 50 µL portions in 0.5 mL Eppendorf cups. The samples were immediately 
snap-frozen in liquid nitrogen and stored at -80° C until further use. 
The quality of the competent cells was tested by determining the colony forming units (cfu) 
after transformation of a single 50 µL aliquot with 1 ng of pUC18 plasmid carrying an 
ampicillin resistance cassette (see 1.8.2). A serial dilution of the transformed culture was 
prepared and 50µl fractions of each dilution step were plated on agar plates with containing 
the corresponding antibiotic and incubated top-down over night at 37°C. Next day, the 
colonies were counted and from these counts the transformation efficiency was calculated 
corresponding to 1µg input DNA. 
2.8.2 Transformation of DNA in electrocompetent E. coli cells 
In order to express the proteins of interest in vivo, the expression plasmid contain the 
sequence of the protein of interest was transformed in E. coli cells. For this purpose a 50 µL 
aliquot of electrocompetent E. coli  cells  was taken from the -80°C storage and transferred 
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on ice. After the cells thawed on ice, 1 µL of plamid DNA, irrespective whether from a mini or 
maxi was added to the cells, gently mixed, transferred to an electroporation cuvette (0.1 cm 
gap). Transfer of the DNA into the cells was caddied out using a Bio-Rad MicroPulser 
electroporator set for electroporation of E. coli. Once the pulse time was between 4 and 5.5 
ms, the cells were resuspended in 1 mL of 2xYT medium, transferred to a 1.5 mL Eppendorf 
cup and incubated at 37°C shaking at 180 rpm for 30-45 minutes. The transformed cells 
were harvested by centrifugation at 1500 g for 2 minutes in a benchtop centrifuge. 800 µL of 
the supernatant was discarded, the cells were re-suspended in the remaining supernatant 
and plated on a 2xYT agarose-plate containing 2% glucose and the appropriate antibiotics, in 
order to retain transformed plasmid as well as the helper plasmid of the given E. coli strain. 
The plates were incubated top-down overnight at 37° C. 
2.8.3 Expression of protein 
For production of the protein of interest all freshly transformed cells from a 2xYT agarose 
plate were scraped off in 3 mL LB medium and used to inoculate prewarmed 50 – 200 mL LB 
medium containing 2% glucose and the antibiotic needed for retaining the expression 
plasmid. The presence of the 2% glucose additional represses the expression of the plasmid 
encoded protein through the lac-operon. The expression culture was then grown to an OD600 
of 0.7 shaking at 37°C and  180rpm and protein expression was induced by addition of IPTG 
to a final concentration of 1 mM. After induction, the expression cultures were incubated at 
different conditions: a) 37° C, 180 rpm for 3 hours; b) 30° C, 180 rpm for 4 hours; c) 22° C, 
180 rpm for 5 hours; d) 18° C, 160 rpm overnight (16-20 h). For protein purification, cells 
were finally harvested by centrifugation at 4°C and 3220 g for 20 minutes in 50 mL Falcon 
tubes. The supernatant was discarded and cells were either used immediately for protein 
extraction or were stored at -20° C until further use. 
2.9 Protein purification 
2.9.1 Protein extraction from E. coli cells 
For extraction of the cytosolic proteins from E. coli cells under native conditions the cell pellet 
from a 50 mL expression culture (2.8.3) was re-suspended in 3 mL native lysis buffer. The 
cells were lysed by adding 30 µL lysozyme (20 mg/mL) per 50 mL tube and incubating them 
on ice for 30 minutes. Additionally, cells were sonicated on ice by three 20-second intervals 
with 20-second pauses in-between. Finally a protein inhibitor cocktail (1 tablet per 1 mL H2O) 
and PMSF (serine protease inhibitor) were added to the lysate to a final concentration of 
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1:100 dilution and 1 mM, respectively. The soluble proteins were separated from the cell 
debris by a 15-minute centrifugation at 15300 g and 4°C. The supernatant containing the 
soluble protein was transferred in a 15 mL tube. The insoluble fraction in the pellet was re-
suspended in 0.5 or 1 mL 8M urea and used for analytical purposes. All samples were stored 
at 4° C. 
2.9.2 Immobilized metal-ion chromatography (IMAC) purification of 
recombinant protein using Ni-NTA agarose at gravity flow 
The His6-tagged mTKIN was routinely purified by gravity-flow Ni-NTA affinity chromatography. 
For each purification, a fresh 500 µL aliquot of re-suspended Ni-NTA agarose (50 % 
suspension) were added to the soluble protein fraction derived from the lysis (2.9.1) of each 
50 mL expression culture. Before adding the Ni-NTA agarose to the soluble protein fraction, 
an aliquot was taken aside for later analytical purposes. The mixture of the soluble proteins 
and the Ni-NTA agarose was incubated for an hour on a roller at low speed and 6-8°C. The 
mixture was than transferred to a 5 mL polypropylene column and the flow though was 
collected. The Ni-NTA agarose was washed twice with 4 mL washing buffer. Aliquots from 
the washing steps were collected for analytical purposes. Finally, 1 mL of elution buffer was 
added to the Ni-NTA agarose and the column flow was stopped. After one hour incubation of 
the Ni-NTA agarose with the elution buffer in the column, the first elution fraction was 
collected. The elution step was repeated two to three more times subsequently without 
performing one hour incubations, thus producing three to four separate 1 mL elution fractions. 
All elution fractions, as well as the flow-through and other aliquots from the purification 
procedure were stored at 4°C until further use. 
2.9.3 IMAC purification of recombinant protein using Ni-NTA magnetic beads 
For Ni-NTA affinity purification of smaller amounts of His6-tagged protein (<1ml), such as 
derived from in vitro expression, Ni-NTA functionalized magnetic beads were used as 
chromatography matrix. Handling of the beads was carried out using a magnetic stand 
holding the beads in place while the supernatant is taken off carefully with a pipette. First, 
100 µL of re-suspended Ni-NTA magnetic beads were added to the protein containing 
solution and incubated for 1 hour on a roller at low speed and 6°C. Eppendorf cup was 
placed in the magnetic stand, beads were collected and supernatant was removed. After 
collecting the supernatant, the beads were washed twice with 500 µL NPI-20 with short re-
suspension of the beads in the buffer between the steps by removing the tube from the 
magnetic stand. The protein was finally eluted twice with 50 µL NPI-250 and once with 100 
Materials and Methods 
 31
µL with 5-10 minute incubation time in-between. 
2.9.4 IMAC purification of recombinant protein using a Ni-NTA Superflow 
cartridge on an FPLC system 
In order to optimize the purification procedure of the His6-tagged mTKIN, a 1 mL Ni-NTA 
Superflow cartridge was used in combination with a ÄKTApurifier FPLC system. The 
cartridge was washed with 15 column volume (CV) of 0.5 M NaOH at a flow rate of 0.5 
mL/min before each purification run and equilibrated with 10 CV NPI-10. The extracted 
soluble protein fraction from a mTKIN expressing culture was centrifuged two times instead 
of just once (2.9.1) to remove any remaining larger particles potentially clogging the FPLC 
system. The soluble protein fraction was loaded in a 10 mL loop connected on the FPLC 
system. If the volume of the sample was less than 10 mL, the volume was adjusted with NPI-
10. After injection, the cartridge was first washed with 2 CV NPI-10 followed by a wash with 
10 CV of 96% NPI-10 and 4% NPI-250 simulating a wash with NPI-20. The bound protein 
was then eluted with different gradients starting with 4% and ending with 100% NPI-250. The 
presence of proteins was monitored online by light absorption at 280 nm. The flow-through 
fraction (10 mL), the wash fractions (2 mL) and the elution fractions (1-2 mL) were collected 
and stored at 4° C. The flow-through and peak fractions were used for further analysis by 
SDS-PAGE (2.10.1) 
2.9.5 ATP-agarose affinity chromatography batch purification 
To increase the purity of the recombinantly expressed mTKIN, Ni-NTA purified sample was 
further purified relying on the ATP-binding property of mTKIN. Four commercially available 
matrices (ATP Affinity Test Kit, JenaBioscience) differening by the way of ATP-immobilization 
on agarose were tested: aminophenyl-ATP-agarose, C10-spacer (AP-ATP-agarose), 8-[(6-
amino)hexyl]-amino-ATP-agarose (8AH-ATP-agarose), N6-(6-amino)hexyl-ATP-agarose 
(6AH-ATP-agarose) and 2'/3'-EDA-ATP-Agarose (EDA-ATP-Agarose). The chemical 
structures of all four molecules are presented in Figure 2-3. 
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Figure 2-3: Chemical models of the four differently functionalized ATP-agaroses batches with 
ATP (models adopted from: http://www.jenabioscience.com/images/ab4587dada 
/AK-102.pdf ). In the 6AH and 8-AH-agarose the ATP is immobilized over two 
different connection points of the adenine base. In the AP-ATP-agarose the ATP 
is immobilized through the γ phosphate and in the EDA-ATP-agarose through the 
two OH groups of the ribose. 
All washing and elution buffers were prepared as described in the kit’s manual with the 
exception that sodium-orthovanadate and DTT were excluded from the binding, wash and 
elution buffer. Sodium-orthovanadate is an ATPase inhibitor, which would hamper our goal to 
yield functionally active kinesin. Further, DTT was not added as our engineered mTKIN 
contains no cystine residues in its structure. 50 µL of each ATP-agarose was transferred to a 
1,5 mL Eppendorf cup and equilibrated three times with 330 µL of washing buffer. In order to 
separate the agarose from the buffer, the tubes containing an agarose were centrifuged at 
1000 g for one minute, as suggested by the manufacturer. After centrifugation, the 
supernatant was carefully removed from the tube. For the affinity screening with each of the 
four ATP-agaroses, 1 mL elution of the Ni-NTA purified mTKIN (2.9.3) was mixed with 250 
µL binding buffer supplied with the kit and 310 µL of the given mixture were added to each 
ATP-agarose. The agarose-sample mixtures were incubated on a roller for 2 hours at 6°C. 
The flow-through fractions were collected. And the ATP-agarose batches were washed three 
times with 500 µL washing buffer. All wash fractions were collected. Finally, 120 µL elution 
buffer was added to each ATP-agarose and incubated on a roller at 6°C for 20 minutes. The 
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elution fractions were collected and the elution step was repeated to evaluate the efficiency 
of the elution.. After elution ATP-agarose batches were preserved in 500 µL 20% ethanol. 
The samples, ATP-agaroses and the fractions were kept on ice during the whole process. 
2.9.6 FPLC using the EDA-ATP-agarose 
To optimize the purification conditions using EDA-ATP-agarose, The batch purification 
protocol was transferd to the FPLC system. For that, a 1 mL Pharmacia cartridge was 
packed with ~250 µL bed volume of the previously used an the remaining unused EDA-ATP-
agarose and equilibrated with 10 CV of ATP-agarose wash buffer before use. For the test 
purification, Ni-NTA FPLC elution fractions contain the mTKIN were pooled and diluted 1:5 
with ATP-agarose binding buffer. The samples were loaded in a 10 mL loop. Prior injection of 
the sample, the column was additionally equilibrated with 5 CV wash buffer at 1 mL/min and 
the sample was injected at 0.5-0.2 mL/min. Unbound proteins were washed away with 7 CV 
of wash buffer and finally bound proteins were eluted with wash buffer containing 1mM ATP 
at 0.5 mL/min either in continuous flow or with a 20-minute pause after first detection of ATP. 
ATP was monitored by light absorption at 254 nm and protein at 290 nm. All fractions were 
collected an stored at 4°C and the first elution fraction was further analyzed. 
2.9.7 Concentrating of proteins 
For producing a sample with higher protein and thus mTKIN concentrations the Ni-NTA 
FPLC purified fraction which contained mTKIN were pooled and loaded in a molecularporous 
membrane tubing with cut-off size of 3500 kDa. The sample-filled tubing was sealed on one 
end with a knot and with a clamp and placed in flakes of solid PEG 6000. After achieving the 
wanted volume reduction the fluid in the tubing was collected at one end and the tubing was 
cut on the other end. The sample was collected from the dialysis tubing with a pipett. 
2.10 Sample protein composition analysis 
2.10.1 SDS-PAGE 
SDS-PAGE analysis of protein extracts was performed using two different gels, depending 
on the quality requirements. For broader screenings the SDS-PAA gels were prepared using 
a multiple gel caster. For casting the gels a 5 cm long 15% polyacrylamid separation gel was 
poured in the gel caster and overlaid with isopropanol. After polymerization, the isopropanol 
was removed from the gel caster, which was subsequently filled with 4% polyacrylamid 
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stacking gel. A comb was placed per one gel section. The distance between the bottom of 
the comb formed pockets and the front of the separation gel was ~1 cm. For electrophoretic 
separation of proteins, samples are mixed with 4x Laemmli sample buffer and boiled for 5 
minutes. Meanwhile, a gel is placed into the electrophoresis chamber. The comb is removed 
and the chamber is filled with Laemmli running buffer. After loading the gels with sample 
material, they were first run at 80 V until the Bromophenol blue front entered the separating 
gel (~15 min), before the currency was elevated to 200 V for the remaining time. For a more 
precise separation of the proteins originating from more specific experiments ready made 
NuPAGE® Bis-Tris gels from Invitrogen were used. With these gels, SDS-PAGE was 
performed using 1x MES as running buffer. Sample preparation before loading onto gels 
comprises mixing the sample with 4x Laemmli loading buffer. Equivalent of 1 µL of the 
original sample were loaded per pocket, where high concentration of mTKIN were expected, 
whereas 3-6 µL of the original sample were loaded per pocket if the concentration of mTKIN 
were expected to be relatively low. A prestained protein ladder (5 µL per lane, precision plus 
protein standard, BioRad) was used for relative comparison of the size of the proteins in the 
other lanes. For visualization of the separated proteins the gels were stained with Coomassie 
brilliant blue R-250 (see 2.10.2) or used for western blotting (see 2.10.3). 
2.10.2 Coomassie staining 
Coomassie brilliant blue R-250 is a dye usually used to uniformly stain all of proteins 
contained on a gel. The dye binds unspecifically to arginines and aromatic amino acids. For 
staining the gels were first incubated in a solution with Coomassie dye for 20 to 30 minutes 
under a continuous linear shaking motion. The dye containing solution was exchanged with a 
destaining solution and a rolled up cellulose tissue (Kleenex) was placed in the vessel to 
absorb the Coomassie dye released from the gels. The gels were destained on a linear 
shaker for half an hour after which the destaining solution was exchanged with deionized 
water and the tissue was replaced with a new one. The gels were left overnight on the bench 
to further destain and finally documented using a CCD camera and a white backlight. 
2.10.3 Western blot 
Proteins separated by SDS-PAGE were transferred from the gel onto a nitrocellulose 
membrane by a wet blotting method. The transfer was performed in a TE 22 Mighty Small™ 
Transphor tank transfer unit containing blotting buffer at 400 mA for one hour. After transfer, 
the membranes were blocked by incubation in PTM for 1 hour of overnight at 6°C under a 
slow continuous motion of the vessel with the blocking buffer. Next, the blocking buffer was 
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exchanged with blocking buffer containing a specific detector of choice. Streptavidin-HRP 
conjugate (1:2500 in PTM) for biotin detection and anti-His-mouse antibody (1:2000 in PTM) 
for 6xHis detection were used, since the expressed mTKIN carries a 6xHis-tag and biotin 
(Avi-tag). For the detection of mTKIN presented on M13 bacteriophages an anti-PIII-mouse 
antibody (1:1000 in PTM) was used. After one hour incubation at room temperature and 
continuous motion with the first detector the membranes were washed 2-3 times in PBS-T for 
5 minutes. The membranes hybridized with anti-His (mouse) and anti-PIII (mouse) antibodies 
were then further incubated with an anti-mouse-HRP antibody (1:5000 in PTM) for a further 
hour. After washing away the excess antibodies 2-3 times with PBS-T for 5 minutes each, 
CN/DAB was given to the membrane as a HRP substrate. The product of the reaction 
precipitates on the position where the detected protein is. Since the precipitate has a dark 
brown to black colour, the position of the protein on the membrane can easily be seen. The 
colouring reaction was stopped with de-ionized water and the blots were dried between two 
pieces of whatman-paper. For documentation, blots were scanned with a regular office color 
scanner. 
2.10.4 Mass spectrometric identification 
Mass spectrometric analyses were performed in order to further verify the integrity of mTKIN 
as well as to identify the co-purified proteins. For this purpose 6 µL of a Ni-NTA affinity 
purified mTKIN (FPLC) was run on a SDS-PAGE (15% PAA). Gel was stained with 
Coomassie in order to detect the proteins present in the sample. Five detected bands (Figure 
3-9) were cut out of the gel in duplicate. One of the samples was digested with Trypsin 
(serine protease) and the other with Asp N endoproteinase according to an adapted protocol 
from Kaiser et al. (Kaiser et al. 2008). The masses of the produced peptides were analyzed 
on a HPLC coupled ESI-Orbitrap mass spectrometer. Recorded masses of the peptides were 
used to identify the corresponding proteins using the Mascot search algorithm using the 
Proteome Discovery 1.1 software. Protein digest, mass spectrometry and mass spectra 
analysis was performed by Dr. David Meierhofer (MPI for Molecular Genentics).  
2.11 in vitro protein expression 
A test was conducted to express mTKIN using the EasyXpress Insect Kit II from Qiagen. This 
expression system is based on cell lysate from a Spodoptera frugiperda cell line. In contrast 
to the prokaryotic in vitro expression systems, where template DNA is given directly to the 
lysate, for the eukaryotic expression system RNA template had to be produced first.. The in 
vitro transcription of the template DNA was performed using the kit supplied polymerase, 
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NTP´s and buffer. From the five available reactions, one was performed with RNase-free 
water (negative control), one with the kit´s control DNA (positive control). The remaining 3 in 
vitro transcription reactions were pooled and the reaction was performed with 3 µg purified 
(2.7.5) mTKIN PCR product (2.7.4) as template. 51 µL of the mTKIN in vitro transcription 
reaction was purified with the RNeasy MinElute clean up kit and purified RNA was eluted in 
12 µL of RNase-free water. All RNA was used as template in a single in vitro expression 
reaction. The remaining 24 µL of unpurified mTKIN-RNA were used for an in vitro expression 
of mTKIN in a double reaction volume. This was done under the assumption that the 
produced mRNA was more concentrated in the purified sample than in the unpurified one. 
The RNA produced in the negative and positive control reactions were not purified and used 
for a single in vitro expression reaction as they were. The translation reactions were mixed 
and carried out according to the manufacturers protocol by incubating for 90 minutes in a 
thermomixer at 27°C and 500 rpm. After incubation the reactions were stored at 4°C. 
2.12 Periplasmic expression of protein 
Apart from the classic cytoplasmic expression of proteins, E. coli offers the possibility to 
express proteins in a secretopry fashion. The expressed protein is translocated to the 
periplasm of the cells from where it can by easily extracted by hypotonic shock. However, for 
the transport of the protein into the periplasm the expressed protein has to carry a N-terminal 
leader sequence. For this purpose mTKIN was cloned in the pIT2 phagemid vector which 
possesses a pelB leader sequence allowing translocation of the protein to the periplasm via 
the Sec pathway and an amber stop behind the mTKIN sequence. Expression of mTKIN in 
pIT vector was carried out in the HB2151 E. coli strain. The extraction of periplasmic proteins 
was performed by subjecting the cells to a mild hypotonic shock. Since the inner cell 
membrane is structurally stronger as the outer membrane, it will not break under the effect of 
sudden pressure change by hypotonic shock, while the outer membrane will loose its 
integrity and break up. This results in the release of periplasmic proteins into the solution 
while the cytoplasmic proteins are being confined in the spheroplasts by the inner cell 
membrane. For the periplasmic expression and extraction two different protocols were 
applied. In both cases, the starting material was a 100 mL expression culture whereby LB or 
2xYT medium was inoculated with HB2151 E. coli cells of a previous overnight culture (1:100 
dilution.)  
2.12.1 Protocol I 
The culture in LB medium (100 µg/mL Amp) was grown to an OD600 of 0,5-0,7 at 37° C 
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shaking at 180 rpm. At this point the expression of mTKIN was induced by the addition of 
IPTG to a final concentration of 0,02 mM and further incubated for 16 hours (overnight) at 
16°C and 160 rpm. The cells were harvested on the following day by 30 minute-
centrifugation at 3220 g.. Cell pellet was re-suspended in 30 mL cold PE buffer and 
incubated on ice for 30 minutes. At this point the periplasmic membrane is being destroyed 
by the hypotonic shock achieved through the high sucrose concentration of the buffer. The 
spheroplasts were separated from the periplasm by centrifugation at 3220 g and 4°C for 30 
minutes. The periplasmic proteins containing supernatant was carefully removed and stored 
at 4°C, while the spheroplasts-containing pellet was stored at -20°C until further use. 
2.12.2 Protocol II 
The culture in 2xYT medium (100 µg/mL Amp, 0.1% Glucose) was grown to an OD600 of 0,5 
at 37° C shaking at 180 rpm. At this point the expression of mTKIN was induced by the 
addition of IPTG to a final concentration of 1 mM and further incubated for 16 hours 
(overnight) at 30°C and 180 rpm. The cells were harvested on the following day by 30 
minute-centrifugation at 3220 g. The cells were re-suspended in 2 mL TES buffer for each 50 
mL culture fraction and the hypotonic shock was performed by adding 3 mL 1:5 diluted TES 
buffer to each 50 mL culture fraction. The cells were incubated on ice for further 30 minutes. 
The spheroplasts were separated from the periplasm by centrifugation at 20000 g and 4°C 
for 20 minutes. The periplasmic proteins containing supernatant was carefully removed and 
stored at 4°C, while the spheroplasts-containing pellet was stored at -20°C. 
2.13 mTKIN presentation on phages 
For presentation of mTKIN on a M13 bacteriophage, mTKIN was expressed as a pIII-fusion 
in the pIT2 vector. This is the same vector used for the periplasmic expression of mTKIN, In 
contrast to the expression in HB2151, a non-suppressor strain for amber stops, expression in 
a suppressor strain will lead to a direct fusion of mTKIN-pIII, which are separated on the 
vector only by an amber stop. 
2.13.1 mTKIN presenting phage production and preparation 
Both of the two commonly used suppressor strains for phage presentation, TG 1 and XL-1 
Blue, were used to present mTKIN on the phage surface. For this purpose electrocompetent 
cells of the two strains were transformed with the pIT2/mTKIN construct as in 2.8.2 and 
grown on ampicillin containing 2xYT agar-medium. Single colonies were picked and used for 
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inoculation of 4 mL of 2xYT medium (100 µg/mL Amp and 2% glucose). The starting cultures 
were grown overnight at 37°C and 180 rpm. The starting cultures were used on the following 
day for inoculation of 100-200 mL of 2xYT medium (100 µg/mL Amp and 2% glucose). The 
cultures were grown to OD600 ≈0,5 and divided in two halves. One half was infected with 1010 
cfu M13K07 helperphage, the other with 1010 cfu of Hyperphage helperphage. The infected 
cultures were incubated at 37° C in a stationary incubator for 30 minutes before the cells 
were collected by a 10 minute-centrifugation at 3220 g and 20°C. After re-suspending the 
cells in the original culture volume of 2xYT medium (0.1% glucose, 100 µg/mL Amp and 60 
µg/mL kanamycin), the cultures were incubated overnight at 30° C and 180 rpm. The 
handling of the cultures as of the moment of infection were performed in disposable vessels. 
On the following day the phages were prepared by separating the cells from the phage 
enriched medium by a 10 minute-centrifugation at 3220 g and 4°C in 50 mL tubes. 42,5 mL 
supernatant of each tube was mixed with 7,5 mL of phage precipitation buffer containing 
PEG, which allows the phage to precipitate. Precipitation was performed by two and a half 
hour incubation on ice and a subsequent centrifugation at 3220 g and 4° C for 30 minutes. 
The pellets in each 50 mL tube were shortly air-dried and re-suspended in 500 µL PBS or 
other buffer suitable for downstream experiments. After transferring the re-suspended 
phages into 2 mL Eppendorf cups, a 10 minute centrifugation at top speed using bench 
centrifuge was performed to remove remaining cells or cell debris and the phage containing 
supernatant was transferred to a fresh vessel. 
2.13.2 M13KO7 helperphage preparation 
Large quantities of M13KO7 helperphages were needed for superinfection of E. coli cells 
bearing pIT2/mTKIN phagemids as well as for comparative analytical purposes. For this a 
single helperhpage plaque was needed as a starting point. Hence, a serial dilution of 
M13KO7 (10-1-10-12) in 90 µL PBS was prepared from a phage stock. The dilutions 10-7-10-11 
were mixed with 100 µL of TG-1 culture grown to an OD600 of 0.5 and incubated for 30 
minutes at 37°C. Meanwhile 2xYT TOP-agar was dissolved in a microwave and kept in a 
liquid state at 43° C. Next, the phage-TG 1 mixtures were added to 4 mL aliquots of the TOP-
agar, gently mixed and immediately poured onto a 2xYT agar plate. After solidifying the 
plates were incubated top down at 37° C overnight. Next day, several 4 mL 2xYT medium 
aliquots were inoculated with single plaques from the plates containing M13KO7 infected TG 
1 cells. The starting cultures were grown at 37°C and 180 rpm for three to four hours and 
used to inoculate 500 mL 2xYT medium filled flasks. The cultures were grown overnight at 
37° C and 180rpm shaking. Harvesting of phage particles was performed as in 2.13.1. 
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2.13.3 Phage titration 
The concentration of prepared phages can be determined relative to their ability to infect E. 
coli cells by monitoring the amount of infectious phages carrying the recombinant phagemid 
vector after plating infected cultures onto agar plates containing the appropriate antibiotics. 
All phage titrations were carried out using the E. coli strain TG1. First a starting culture was 
grown overnight at 37°C and 180 rpm in 2xYT medium. The next day, this was used to 
inoculate 50 mL of 2xYT medium and the culture was incubated at 37°C and 180 rpm until 
OD600 =0,5. Meanwhile, of each phage preparation a 10-times dilution series (factor 101-1012) 
in 90 µL PBS was prepared in a 96-well plate. Next, phage infection was carried out by 
mixing 100 µL of TG 1 cells with each of the 90 µL phage dilutions on the 96-well plate. The 
plate with the samples was incubated for half an hour at room temperature. After infection, 
10 µL of each dilution was carefully spotted on a single 2xYT agar medium so that it 
occupied only a distinct area . In addition, control aliquots of the TG 1 culture, PBS, phage 
preparation and a mix of the used PBS with TG 1 cells were also spotted on each agar-plate. 
The 2xYT agar medium used for titration contained 2 % glucose and 60 µg/mL kanamycin for 
helper phages titration or 2 % glucose and 100 µg/mL ampicillin for titration of phagemid 
carrying phages. The agar-pates were left to dry at room temperature until the aliquots were 
absorbed in the agar medium and incubated top down at 37° C overnight. The concentration 
was determined by multiplying the number of observed colonies with the corresponding 
dilution factor and 211, which allows to express the phage concentration in colony forming 
units per mL phage suspension (cfu/mL). 
2.14 Production of microtubules 
Microtubules (MTs) are necessary for the biochemical and mechanochemical 
characterization of kinesins, as kinesins bind and move on MTs. Microtubules were were 
polymerized from lyophilized bovine tubulin and X-rhodamine labeled tubulin. First, tubulin 
was dissolved to a concentration of 4 µg/µL in BRB 80 buffer supplemented with 1 mM GTP 
and incubated at 37° C for at least 20 minutes to polymerize. The polymerized MTs were 
then stabilized by adding BRB 80 supplemented with 1 mM GTP and 200 µM taxol until an 
end-concentration of 20 µM taxol was reached. Finally, MTs, were further diluted 1:200 in 
BRB 80 supplemented with 1 mM GTP and 20 µM taxol, separated in 100-200 µL aliquots, 
snap-frozen in liquid nitrogen and stored at -80° C. Before use the MTs were thawed at 37°C 
and incubated for at least 10 minute at the same temperature. The procedure to assemble 
microtubules using mixture of tubulin and X-rhodamine labeled tubulin (ROX-MTs) was the 
same as for unlabeled MTs, except that the buffers contained 10% glycerol. All vessels used 
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for ROX-MT production were wrapped in aluminum foil for protection from light.  
2.15 Determination of ATP hydrolysis kinetics of mTKIN using a 
coupled NADH oxidation enzyme assay 
The coupled NADH oxidation assay was used to observe the steady-state kinetics of ATP 
hydrolysis by mTKIN (Gilbert and Mackey 2000). There are two key features of the assay 
(Figure 2-4). 
 
Figure 2-4: Reaction scheme of the NADH oxidation coupled observation of a kinesin (K) 
ATPase activity. Figure taken from Gilbert and Mackey 2000; and the NAD+ and 
NADH ultraviolet light absorption spectra adopted from 
http://en.wikipedia.org/wiki/File:NADNADH.svg 
First, it replenishes the hydrolyzed ATP form ADP thus simulating a constant ATP 
concentration. Second, the reaction stoichiometry between the oxidation of one NADH is 
equivalent to the hydrolysis of one ATP. The kinesin mediated ATP hydrolysis reaction was 
performed in a buffer containing 2 mM MgCl2, 1 mM DTT, 3 mM phosphoenol pyruvate 
(PEP), 0.2 mM NADH, 50 mM Tris-acetate pH 7.5, 1.75% (v/v) pyruvate kinease/lactose 
dehydrogenase solution and 2-0.1 mM ATP (Matsushita et al. 2009). The reactions were 
carried out in 200 µL reaction volumes on a 96-well microtiter-plate. The oxidation of NADH 
was observed by the loss of light absorption at 340 nm in a microtiter-plate reader. A reaction 
containing no NADH was used as a blank, since microtubules absorb light at 340 nm. 
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2.16 in vitro motility assay 
To investigate the mechanochemical property of mTKIN to transport microtubule an in vitro 
motility assay was performed. The experiment is based on the mode of transport. Kinesin 
molecules are fixed onto a surface and added polymerized MTs are being moved in a 
seemingly gliding manner (Figure 1-8, B). First, a flow cell was build from a microscope slide, 
double sided adhesive tape and a cover slip. The flow cell was then loaded with kinesin in a 
buffer containing 1 mM ATP and incubated for 5 minutes. The buffer was than exchanged 
against ROX-MTs (20 ng/µL) supplemented with 1 mM ATP by extracting the buffer from one 
side of the chamber with a kimwipe and adding the ROX-MTs from the other side of the flow 
cell. The flow cell was than immediately used for microscopy. The microtubules were 
observed using x63 objective. Using normal fluorescence microscopy the plane was found 
where the microtubules were being bound to the kinesin coated surface. A time series of 60 
images within 3:42 minutes where taken from a chosen area using laser scanning of the 
kinesin coated plane. This way a more precise images could be taken in comparison of 
standard fluorescence microscopy since all of the ROX-MTs which are bound to kinesin lie in 
the same plane along all their length. The movement was then observed by assembling a 






The goal of this investigation was to express and characterize a cystein-free engineered form 
of the thermostable kinesin mTKIN. First, optimal expression conditions for mTKIN regarding 
temperature, incubation time and host strain usage were determined to obtain soluble protein. 
Additionally, alternative strategies for the expression of mTKIN were assessed. Next, 
chromatography procedures for the isolation of potentially active mTKIN were developed for 
batch purification as well as on an FPLC-system. Furthermore, the presentation of the 
mTKIN on M13 bacteriophage surface was assessed in combination with different host 
strains and helperphage systems. Finally, the activity of the mTKIN was investigated by 
measuring its ATPase activity and its ability to move along microtubules in an in vitro motility 
assay. 
 
3.1 Optimization of growth conditions for soluble expression of the 
mTKIN in the vector pQDKG2 
The aim of these studies was to obtain an optimized protocol for the expression of mTKIN in 
order to yield mainly soluble protein in the cytoplasm. First parameters under investigation 
were the influence of temperature and induction time. This analysis was carried out in an E. 
coli strain regularly used to obtain in vivo biotinylated proteins in our laboratory (AG Konthur), 
namely BL21 (DE3) STAR pRARE3. E. coli cells were transformed with the pQDKG2/mTKIN 
followed by expression of the construct at varying temperatures and induction times. For this, 
initial starting cultures were split at OD600 ≈0.7 , induced with IPTG and placed at differerent 
temperatures for further growth, 37°C, 22°C and 18°C. The induction times were accordingly 
modified to 3h, 5h and 18h respectively. Cells were harvested and soluble and insoluble 
protein fractions of the total cell lysates were used for analysis. Triplicate SDS-PAGEs were 
performed with 1 µL of each fractions from the different expression condition. One of the gels 
was used for visualisation of the proteins by Coomassie staining, while the other two gels 
were used to transfer the proteins to membranes by Western blotting. Streptavidin-HRP 
conjugate was used for detection of all biotinylated proteins on one of the blots. On the other 
blot, a mouse α-His antibody was used in combination with a HRP-coupled rabbit α-mouse 
antibody for detecting all His6-tagged recombinant proteins. Comparing the three detection 
strategies a strong band at ~60 kDa can be seen in both blots which does not stand out in 
the Coomassie stained gel (Figure 3-1). The observed size of ~60kDa corresponds well with 
the in silico calculated size of recombinant biotinylated mTKIN which is ~56 kDa. The 
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Immunoblots also demonstrate that mTKIN is in vivo biotinylated and possesses the 
hexahistidine expression-tag. The expression of mTKIN at 18°C and induction time of 18 
hours yielded larger amounts of mTKIN and smaller amounts of N-terminal degradation 
products in the soluble protein fraction than under the other expression conditions. 
 
Figure 3-1: Comparison of mTKIN expression in BL21 (DE3) Star pRARE3 at different 
temperatures and induction times. 1 µL of the soluble protein fraction (SN) and 
insoluble protein fraction (P) from a 50 mL expression culture were distributed on 
gradient SDS-PAA gels in triplicate. The first gel (right) was stained with 
Coomassie, the second gel (middle) was blotted and hybridized with streptavidin-
HRP and the third (left) was blotted and hybridized with mouse α-His and rabbit α-
mouse-HRP antibodies. Biotin-labeled GST and His6-tagged ubiquitin (Ubi8) were 
used as positive control for the hybridization. M is a pre-stained protein ladder. 
The red pointer and boxes highlight the position of the Avi-His6-tagged mTKIN. 
 
In the next step four different E. coli host strains were asses for their ability to produce more 
full-length mTKIN and less N-terminal degradation products. The strains under investigation 
were: BL21 (DE3) Star pRARE3, BL21 (DE3) pLysS, BL21 CodonPlus (DE3)-RIL and 
Origami B (DE3) pLacI. Again, mTKIN was expressed in all of the strains and under all of the 
tested conditions. The different pattern of the detected bands in the blots demonstrated that 
mTKIN is being expressed differently in each E. coli strain and the different expression 
conditions applied. The expression of the mTKIN in the four different strains showed also 
some differences in the soluble protein fraction. Figure 3-2 shows the expression of mTKIN 
at 18°C as an example. Strains BL21 CodonPlus (DE3)-RIL and Origami B (DE3) pLacI gave 
the best results. The BL21 CodonPlus (DE3)-RIL cells grew faster and more reproducible 




Figure 3-2: Comparison of mTKIN expression in different E. coli strains by induction for ~18 
hours at a temperature of 18°C. 1 µL of the soluble protein fraction (SN) and 
insoluble protein fraction (P) from a 50 mL expression cultures were distributed 
on 15% SDS-PAA gels. After the electrophoresis the gels were blotted and 
hybridized with mouse α-His (mouse) and rabbit-α-mouse-HRP antibodies. M is a 
pre-stained protein ladder. The red pointer highlight the position of the Avi-His-
tagged mTKIN and the blue boxes highlight the mTKIN degradation products. 
 
3.2 In vitro expression of mTKIN 
This experiment was conducted to asses the possibility to obtain soluble mTKIN using a 
eukaryotic in vitro expression system. The reactions were assembled as described in 2.11, 
with purified and unpurified mTKIN template RNA and a positive control reaction contained in 
the kit (His-tagged luciferase). After expression, the recombinant proteins were harvested 
with Ni-NTA magnetic beads, run on an SDS-PAA gel and transferred to a membrane. 
Immunostaining with α-His antibody revealed a faint signal for the positive control at ~60 kD 
and a visible signal at ~55 kDa corresponding to the mTKIN elution fractions of the reaction 




Figure 3-3: Analysis of the in vitro translation reactions after Ni-NTA purification of His6-
tagged proteins. 6 µL of the reaction mix (T) the flow-through (FT), first wash (W1) 
and first elution (E1) fractions from the not purified transcription fractions were 
loaded on gradient gel. The gel was blotted and hybridized with a-His (mouse) and 
a-mouse-HRP antibodies. M is a pre-stained protein ladder. The red pointer 
highlight the position of the Avi-His-tagged mTKIN and the blue circle highlights 
the position of a faint band from the His-tagged luciferase, which is hardly visible 
after digitalization of the blot. 
 
The attempt to further purify the in vitro expressed mTKIN with ATP-agarose resulted in no 
detectable mTKIN, neither on Coomassie stained SDS-PAA gels nor by detection with an 
anti-His antibody on a western blot. 
 
3.3 Periplasmic expression of mTKIN 
Alternatively, targeted expression of mTKIN to the periplams of E. coli host cells was 
assessed for yielding larger amounts of soluble protein. Expression was conducted using the 
pIT2/mTKIN construct in E. coli strain HB2151. Two different protocols were applied with 
slightly different media components and IPTG concentration. Western blot examination of the 
periplasmic fractions loaded beside lysed spheroblasts of the same sample showed that 
Results 
 46
His6-tagged protein was only present in the spheroblasts (Figure 3-4). After a native lysis of 
the spheroblasts and separation of the soluble from the insoluble proteins, the detection with 
an α-His antibody on a western blot showed that the His6-tagged mTKIN was present in both 
fractions at similar concentration. 
 
Figure 3-4: Analysis of the periplasmic expression of mTKIN applying two different protocols. 
On the left blot, 6 µL of the periplasmic preparations (PP) and aliquot of the 
spheroblasts (SB) were loaded on a 15% SDS-PAA gel, blotted and hybridized 
with mouse α-His and rabbit α-mouse-HRP antibodies. A pre-stained protein 
ladder (M) was used for size orientation. The position of the His6-tagged mTKIN is 
highlighted by the red box. On the right blot, 1 µl of the soluble (SN) and insoluble 
(P) fractions of the lysed spheroblasts were loaded on a 15% SDS-PAA gel, 
blotted and hybridized with mouse α-His and rabbit α-mouse-HRP antibodies. 
3.4 Purification screening using Ni-NTA agarose by gravity-flow 
A simple procedure to isolate mTKIN from cell lysate applying Ni-NTA agarose batch 
purification by gravity-flow was assessed. Following the standard purification protocol 
recommended by the manufacturer resulted in co-purification of many other proteins together 
with the mTKIN, as can be seen on a Coomassie stained gel after SDS-PAGE (Figure 3-5). 
From western blots of such purification it was observed that the Avi-His6-tagged mTKIN is 
depleted from the flow-through fraction and enriched in the elution fractions. A 4-fold 
enrichment factor is achieved through volume difference between the cell lysate from a 50 
mL culture and a single elution fraction. When larger expression cultures are used for 




Figure 3-5: Analysis of the Ni-NTA gravity flow purification fractions from a 200 mL mTKIN 
expression culture in BL21 CodonPlus (DE3)-RIL. 1 µL of the insoluble (P) and 
soluble (SN) protein fraction collected after cell lysis as well as of the flow-
through (FT), first wash (W1) and all four elution fractions (E1-4) were separated 
on gradient SDS-PAA gels in duplicate. One gel was stained with Coomassie 
(right), the other was blotted and subsequently hybridized with streptavidin-HRP 
(left). Biotinylated GST was used as control for the hybridization and the 
prestained protein ladder (M) was used for size orientation. Red boxes highlight 
expressed mTKIN. 
3.5 Purification of mTKIN using immobilised ATP affinity 
chromatography 
To further increase the purity of mTKIN after Ni-NTA agarose batch purification by gravity 
flow, the ATP-binding property of kinesins was used. Four available matrices differing in the 
way the ATP is linked to the agarose were tested: aminophenyl-ATP-agarose, C10-spacer 
(AP-ATP-agarose), 8-[(6-amino)hexyl]-amino-ATP-agarose (8AH-ATP-agarose), N6-(6-
amino)hexyl-ATP-agarose (6AH-ATP-agarose) and 2'/3'-EDA-ATP-Agarose (EDA-ATP-
Agarose). In the first instance, all ATP-agaroses were incubated with Ni-NTA purified mTKIN 
(B/GF procedure) from a 50 mL Origami B (DE3) pLacI culture. Western blot analysis using 
streptavidin-HRP as a detector, small amounts of mTKIN were found only in the elution 
fraction of EDA-ATP-agarose (data not shown). The repetition of the whole affinity 
chromatography procedure including Western blot analysis with Ni-NTA elution fractions 
originating from 100 mL BL21 (DE3) pLysS and later from 200 mL BL21 CodonPlus (DE3)-
RIL. expression cultures a stronger enrichment of the mTKIN with the EDA ATP-agarose was 
observed. Figure 3-6 shows a Coomassie stained SDS-PAA gel and a corresponding 
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Western blot analysis with streptavidin-HRP. Considerable enrichment and decrease of 
mTKIN can be observed in the elution and the flow-through fractions of EDA-ATP-agarose, 
respectively. In contrast, the other three ATP-agaroses did not show to specific retain mTKIN 
as most of the mTKIN was found in the flow-through fractions. from the other three types of 
ATP-agarose batches. The batch purification method applying ATP-affinity chromatography 
still results in some unspecific proteins in the elution fractions that can be detected on 
Coomassie stained SDS-PAA gels as well as in Western blots hybridized with streptavidin-
HRP. 
 
Figure 3-6: Batch purification of Ni-NTA (B/GF) pre-purified mTKIN from a 200 mL BL21 
CodonPlus (DE3)-RIL culture applying four different types of ATP-agaroses (Jena 
Bioscience). 4 µL of sample of the flow-through (FT) and elution fractions (E1, E2) 
from each ATP-agarose purification, were separated on a gradient SDS-PAA gel in 
duplicate. One gel was stained with Coomassie (right), the other was blotted and 
hybridized with streptavidin HRP (left). A pre-stained protein ladder was used for 
size orientation. The red pointers highlight the ATP-agarose enriched mTKIN. 
3.6 FPLC purification with Ni-NTA superflow cartridge 
Aim of this study was to determine the optimal imidazole concentration for mTKIN elution and 
to reduce the background of co-purified protein at the same time. In the first attempt, a 
soluble protein fraction extracted from a 100 mL expression culture was loaded on a FPLC-
system equipped with a 1 mL Ni-NTA superflow cartridge. Elution was carried out applying a 
linear gradient from 19.6 mM to 250 mM imidazole concentration, which resulted in a single 
peak at 70 mM imidazole. SDS-PAGE and Western blot analysis discovered that the peak 
contained five proteins in total, two larger and two smaller proteins than mTKIN. At the same 
time, mTKIN seemed to be eluted in higher concentration at slightly elevated imidazole 
concentrations compared to the other proteins. For comparison, recombinant Avi-His6-tagged 
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ubiquitin precursor protein (Ubi8) was purified with the same column and gradient. This 
resulted in a peak at 96.7 mM imidazole concentration, which corresponds with the shifted 
elution of the mTKIN relative to the other detected proteins (Figure 3-7). 
 
Figure 3-7: Overlay of the 280 nm UV-light absorption curves from a Ni-NTA affinity FPLC of 
Avi-His6-tagged mTKIN (blue) and Ubi8 (red) from a protein extract. mTKIN sample 
originated from 100 mL expression culture of BL21 CodonPlus (DE3)-RIL and 
Ubi8 from 50 mL expression culture of BL21 (DE3) Star pRARE3. In both cases, 
elution was performed applying a linear gradient (green), starting from 4% NPI-
250/96% NPI-10 and ending at 100% NPI-250 in a total volume of 100 mL. 
 
To specifically deplete the unspecific proteins, a complex gradient was applied starting with a 
linear gradient from 19.6 mM up to 58 mM imidazole concentration, followed by a first 
isocratic elution step with 130 mM imidazole and a final isocratic elution step with 250 mM 
imidazole (Figure 3-8). This modification to the protocol resulted in a further shift of the 











Figure 3-8: Ni-NTA FPLC purification of mTKIN from a 200 mL BL21 CodonPlus (DE3)-RIL 
culture with a complex gradient (green curve). Proteins were observed through 
absorption at 280 nm (blue curve). The collected fractions are designated with red 
colour. The presented fractions in the zoomed window were used for protein 
composition analysis as well as for functional characterization. The red curve is 
produced by a FPLC run over a Ni-NTA column without protein to represent the 








































35.0 40.0 45.0 50.0 ml

















Figure 3-9: Coomassie stained 15% SDS-PAA gels loaded with fractions of a Ni-NTA FPLC 
purification of soluble protein extracts from 200 mL BL21 CodonPlus (DE3)-RIL 
(upper gel) and Origami B (DE3) pLacI (lower gel) mTKIN expression cultures 
using the same elution gradient. 6 µL of flow-through (X1), wash (A3) and a series 
of elution fractions (B2-B12) were loaded. The third band from the top in the 
elution fractions is mTKIN (red pointer), the other four bands (blue pointers:1, 2, 4 
and 5) correspond to proteins being co-purified with mTKIN. 
 
 
Figure 3-10: Western blot analysis of the Ni-NTA FPLC fractions. Identical gels to those from 
Figure 3-9 were blotted and hybridized with streptavidin-HRP. The samples 
originate from a BL21 CodonPlus (DE3)-RIL (upper blot) and from a Origami B 
(DE3) pLacI (lower blot) expression culture. Red and blue pointers show 




Repeating this purification strategy with pooled mTKIN containing fractions from the previous 
run resulted in a separation of the two larger proteins from the mTKIN. The two larger 
proteins remained in the flow-though fraction, while mTKIN and one of the smaller proteins 
were eluted with the 130 mM imidazole concentration step of the complex gradient. The 
amount of the smaller protein was significantly higher than that of mTKIN (Figure 3-11) 
 
Figure 3-11: Coomasie stained gradient SDS-PAA gel loaded with the flow-though (A1 and A2) 
and series of elution fractions with the 50% NPI-250 (A12-B6) produced by a 
repeated Ni-NTA affinity FPLC purification with pooled mTKIN containing 
fractions as starting sample. The bands highlighted with a blue pointer are the 
unspecific co-purified proteins and the band highlighted with the red pointer is 
the mTKIN. The numbers of the pointers show the corresponding bands from 
Figure 3-9
3.7 Testing if the ATP-agarose is suitable for FPLC purification of 
mTKIN 
Next, a self assembled EDA-ATP-Agarose column was applied using the FPLC to further 
purify potentially active mTKIN from the Ni-NTA purified fractions. Column was loaded with 
pooled mTKIN-containing fractions and bound mTKIN was eluted with an ATP-rich buffer. No 
characteristic peak, but rather a plateau was observed. Western blot examination showed 
that the majority of mTKIN did not bind to the column and was located in the flow-through 
fraction. Elution fractions contained only tiny amounts of pure mTKIN evenly distributed 
throughout all fractions (data not shown). To test the time dependence of mTKIN elution, the 
purification was repeated introducing two 20-minute pauses. One at the initial detection of 
ATP at 254 nm, and a second pause 4 mL after the first. This strategy lead to the elution of 
mTKIN in the fraction directly collected after the first pause, as demonstrated with a visible 
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band in a Coomassie stained SDS-PAGE. An additional second band was detected with 




Figure 3-12: Coomassie stain and western blot analysis of a flow-through (X1) a wash (A2) and 
a series of elution fractions from the FPLC purification with introduced pauses 
using an EDA-ATP-agarose loaded column. The sample of pooled mTKIN 
containing fractions from a Ni-NTA FPLC was injected at 0.2 mL/min and the run 
was paused for 20 minutes right after ATP was first recorded at the detector 
(before fraction A9). This resulted in a visible band of specifically eluted mTKIN in 
fraction A9 on the Coomassie stained gel (upper image, red pointer). The second 
pause before the B1 fraction resulted in a second band detectable only by 
streptavidin-HRP on a western blot (lower image). 15% SDS-PAA gels were used 
for the SDS-PAGE. 
 
3.8 Mass spectrometric identification of mTKIN and co-purified 
proteins 
To find out whether all proteins in the elution fractions of a Ni-NTA purification correspond to 
mTKIN, a mass spectrometry analysis was performed. Five samples corresponding to the 
bands shown in Figure 3-9 , were excised from a Coomassie stained SDS-PAA gel. Samples 
were individually digested with two different proteases and analysed on a HPLC-coupled 
Results 
 54
ESI-Orbitrap mass spectrometer. This analysis confirmed that protein 3 was indeed mTKIN 
(52.41% sequence coverage). Analysis of the spectra from both digests (trypsin and AspN) 
revealed in each case five mTKIN-matching peptides with low false discovery rate (1%) when 
compared with a computationally generated peptide database (Figure 3-13). Additionally the 
two different digest produced together another seven peptides which were identified to be 
characteristic for mTKIN as well as KIF1A, B, and C from Homo sapiens, Mus musculus and 
Rattus norvegicus, as well as Unc-104 from Aedes aegypti, Anopheles gambiae, Drosophila 
melanogaster and Drosophila pseudoobscura pseudoobscura. The other four detectable 
proteins by Coomassie staining (Figure 3-9) were identified as E. coli originating proteins. 
Protein 1 was identified as bifunctional polymyxin resistance protein arnA (48.48% sequence 
coverage), protein 2 was identified as glucosamine-fructose-6-phosphate aminotransferase 
(56.49% sequence coverage), protein 4 was identified as FKBP-type peptidyl-prolyl cis-trans 
isomerase slyD (47.45% sequence coverage) and protein 5 was identified as catabolite gene 
activator (66.67% sequence coverage). 
 
Figure 3-13: Sequence coverage of the mTKIN mass spectrometry analysis. The green 
highlighted peptides are detected peptides with false discovery rate of less than 
1%, the red highlighted peptides with false discovery rate of more than 5% 
3.9 Phage display 
Here, the possibility to present mTKIN on the surface of M13 bacteriophages was assessed. 
For this purpose, pIT2/mTKIN was expressed in combination with two different helperphages 
in two commonly used E. coli strains for phage display, namely TG1 and XL1-blue. The two 
different helperphages M13KO7 and Hyperphage allow either monovalent or multivalent 
display of mTKIN on the bacteriophage surface, respectively. Western blot analysis using a 
mouse anti-pIII monoclonal antibody identified mTKIN-pIII fusion in all types of prepared 
phages, except for the phages produced with hyperphage in E. coli TG1 (Figure 3-14). In 
XL1-blue, phages produced with Hyperphage show more mTKIN-pIII fusion than those 
produced with M13KO7. The expected size of the mTKIN-pIII fusion protein without the pelB 




Figure 3-14: Western blot analysis of the four different mTKIN presenting phage populations 
resulting from the combinatorial application of two helperphages and two E.coli 
host strains. Additionally, the M13KO7 helperphage is loaded as a control and for 
comparison. Respective volumes of a phage preparation were loaded on a 15% 
SDS-PAA gel, and blotted. Wild-type pIII and mTKIN-pIII fusion were detected by 
hybridization with mouse a-pIII monoclonal and rabbit α-mouse-HRP antibodies. 
The blue and red arrows point to wild-type pIII and mTKIN-pIII fusion proteins, 
respectively. The red circle highlights the position of a faint band of mTKIN-pIII, 
which is hardly visible after digitalization of the blot. 
Next to Western blot analysis, the amount of infective phage particles from 50 mL culture 
volumes was assessed by titration. The results showed that the majority of all four types of 
phages were carrying the mTKIN phagemid (Table 3-1) Generally the infection with M13KO7 
yielded more phages than the infection with hyperphage as shown by the combination of XL-
1 host strain with M13KO7 helperphage. In all cases, the ratio between packaged helper 
phage genomes and pIT2/mTKIN phagemids is in the order of 2-3-magnitudes. 
Table 3-1: Titre of infectious phage particles of all four phage populations. Phages produced 
from the four possible combinations of the two E. coli host strains TG 1 and XL1-
blue and the two helper phages M13KO7 and Hyperphage were titrated for 
helperphage genome and for mTKIN-phagemid carrying phages. The number of 
helperphage genome containing and pIT2/mTKIN phagemid containing particles 
was determined by plating on kanamycin or ampicilin containing agar-plates. 
 
Host Helper phage Kanamycin (Helper) 
Ampicilin 
(mTKIN phagemid) 
M13K07 2,1 • 1010 cfu/mL 3,6 • 1012 cfu/mL 
TG 1 
Hyper-phage 1,0 • 107 cfu/mL 2,1 • 109 cfu/mL 
M13K07 1,0 • 1011 cfu/mL 1,5 • 1014 cfu/mL 
XL-1 Blue 
Hyper-phage 8,0 • 108 cfu/mL 2,5 • 1011 cfu/mL 
Results 
 56
3.10 Determining the ATPase activity of mTKIN using the NADH 
oxidation coupled double enzyme ATPase assay 
Measurement of ATP hydrolysis rate allows to determine the activity of kinesins, as they 
require ATP to move along MTs. First, the coupled NADH oxidation assay was successfully 
established using standard 1 cm photometric cuvettes as well as using a microtiterplate by 
directly adding ADP as a substrate. The reduction of light absorption at 340 nm by excess 
ATP in combination with small amounts of ADP as substrate proved that the enzymatic 
system was not inhibited by an ATP to ADP ratio similar to the situation in which a kinesin 
starts producing ADP through ATP-hydrolysis. The kinetic properties of the EDA-ATP-
agarose purified mTKIN expressed in BL21 CodonPlus (DE3)-RIL was assessed by 
performing this assay on a microtiterplate at eight different ATP concentrations and in 
presence or absence of MTs (0.1 µg/mL or ~ 1 mM αβ-tubulin). The same was repeated with 
a 1:2 dilution of a KIF1A-GFP stock solution, a recombinant full-length kinesin-3 from R. 
norvegicus C-terminally fused with His6-tagged GFP, as a control (courtesy of Prof. Lipowsky, 
MPI for Colloids and Interfaces). The total concentrations of the kinesins in the reactions 
were roughly estimated to be ~66 nM for the KIF1A-GFP and ~5 nM for the EDA-ATP-
agarose FPLC-purified mTKIN (Figure 3-15) 
 
Figure 3-15: Comparison between the concentration of KIF1A-GFP stock solution and EDA-
ATP-agarose FPLC-purified mTKIN by SDS-PAGE analysis. Coomassie stained 
15% SDS-PAA loaded with 6 µl of each sample and a prestained protein ladder (M) 
for protein size comparison. 
The NADH oxidation coupled assay showed an intrinsic ATPase activity for both kinesins, i.e. 
in the absence of MTs. However, the rates of ATP hydrolysis in presence of MTs were 




Figure 3-16: Michaelis-Menten curves for the ATPase activity of mTKIN and the positive 
control (KIF1A-GFP) in the presence or absence of microtubules. The V0 values 
were calculated using the Lambert-Beer’s law from the measured ΔE/dt of a 
microtiterplate-format NADH oxidation coupled assays and plotted against the 
different ATP concentrations. 
 
 
The Vmax and the Km values of the mTKIN and the KIF1A-GFP were similar when no MTs 
were present in the reactions (Table 3-2). The presence of MTs raised the kcat of KIF1A-GFP 
around 2.2-fold while the Km was lowered 0.5-fold. The Km of mTKIN was also lowered under 
the same conditions, but less (0.85-fold), while the kcat of mTKIN had increased considerably 





Table 3-2: Evaluation of the Michaelis-Menten curves obtained by the ATPase assay 
measurement of mTKIN and KIF1A-GFP using GraphPad Prism software. The kcat 
values have error around 25%, as they are calculated using only roughly 
estimated protein concentrations. 
 
Reaction Vmax (mmol/L·min) Km (µM) kcat R2 of curve fit 
KIF1A-GFP 0.69·10-3 ± 6.74% 197.6 ± 54.64 ~0.175 s-1 0.8843 
KIF1A-GFP+MTs 1.51·10-3 ± 3.29% 97.9 ± 18.21 ~0.378 s-1 0.9181 
mTKIN 0.74·10-3 ± 4.16% 238.3 ± 39.19 ~2.46 s-1 0.9586 
mTKIN+MTs 3.2·10-3 ± 3.80% 202.5 ± 32.67 ~10.66 s-1 0.9573 
3.11 Microtubule gliding assay 
Finally the ability of immobilized mTKIN to move microtubules was assessed in a motility 
assay. The assay was successfully established with KIF1A-GFP fusion protein, as directed 
gliding movement of the ROX-MTs was observed in a distinct plane scanned by a LSCM 
(Figure 3-17). The plane corresponded to KIF1A-GFP coated surface. Next, this experiment 
was repeated with diluted stocks KIF1A-GFP 1:2 in NPI-250, the elution buffer of mTKIN 
purification on the FPLC-system. The observed gliding motion of ROX-MTs confirmed that 
presence of 125 mM imidazole is not hampering the glide assay mechanics. The glide assay 
performed with a Ni-NTA FPLC-purified mTKIN from 200 mL BL21 CodonPlus (DE3)-RIL 
using a streptavidin-coated slide resulted just in a very low rate of binding of ROX-MTs onto 
the plane where the biotinylated mTKIN was previously enriched and no gliding was detected. 
A 20-times more concentrated Ni-NTA FPLC-purified mTKIN from 400 mL OrigamiB (DE3) 
pLacI expression culture was used in motility assays with standard glass slide and 
streptavidin coated slides. Again only very rare binding events of ROX-MTs onto the mTKIN 
functionalized surface seen and no gliding was recorded. However, the ROX-MTs were 





Figure 3-17: Snapshots taken in same time intervals of three glide assays done with KIF1A-
GFP (positive control), mTKIN (on streptavidin slide) and concentrated mTKIN 
(standard glass slide). The red pointers highlight kinesin driven gliding of ROX-
MTs, the blue pointers highlight immobile ROX-MTs bound to the kinesin coated 
surface and the green pointer highlight the truncation of ROX-microtubule 
segments over time. Yellow magnification bar = 10 µm. 
The full movies of the individual gliding assays presented in Figure 3-17 can be found on the 





The kinesin-microtubules transportation system has been evolved and optimized in nature 
over millions of years and therefore represents an excellent basis for future lab-on-a-chip 
applications. Since it is an active transporting system it can be used for movement of 
macromolecules from one chamber to another. In principle, this could be done selectively 
over channels which the macromolecules can not passage without active transport. The 
possibility to use a kinesin molecule which shows superior stable at higher temperatures and 
possesses a longer half live without loosing its activity and property for nanotechnological 
applications has not yet been described and investigated. Additionally, no attempts to 
present kinesins or mutated kinesin libraries on bacteriophage surfaces for purposes of 
protein engineering has been published. Inevitably, production of specifically tuned kinesin in 
respect of temperature, motility velocity or even substrate specificity by phage display 
selection techniques would allow a much greater flexibility in the construction of future lab-
on-chip or other nanotechnological applications. 
4.1 Expression screening of modified TKIN (mTKIN) 
The modified kinesin (mTKIN) is derived from kinesin-3 (TKIN) from T. lanuginosus (Rivera et 
al. 2007) The major differences are the lack of cysteines and that it is a truncated version of 
the protein (aa1-498). The initial expression attempts in the BL21 (DE3) Star pRARE3 strain 
showed that mTKIN can be expressed as a soluble protein in sufficient quantities (Figure 
3-1). This means that there is no need to use insoluble mTKIN, which then has to be 
solubilised under denaturing conditions and refolded into functional conformation before use. 
The feature of soluble expression becomes especially important in nanotechnology. The 
easier and less time-consuming the production process of a kinesin is, the more useful its 
application possibility in nanotechnological applications will be. All downstream processes 
under investigation in this study were conducted bearing this in mind. The purification and 
characterization studies were initially designed as simple as possible and the produced and 
purified mTKIN was simply stored at 4°C. Hence, the major focus of this study was directed 
towards isolation of mTKIN from the soluble protein fraction of E. coli cell lysates, and the 
insoluble fraction was rather used for comparative reasons, as the insoluble fraction 
contained similar amounts of soluble mTKIN. The expression levels of mTKIN were however 
low in contrast to previously expressed kinesin-3 isoforms (Rivera et al. 2007; Sakowicz et al. 
1999). Because of the low expression levels of mTKIN the corresponding band in the soluble 
protein fraction cannot be easily identified on a Coomassie-stained SDS-PAGE. To be able 
to monitor the difference in mTKIN yield during the expression screening phase all 
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evaluations were carried out by Western blot analysis. Therefore the detection of Avi-His6-
tagged mTKIN with streptavidin on one Western blot and with anti-His antibody on another 
enabled a far better identification of the mTKIN and were mainly used for orientation and 
comparison of the expression patterns under different conditions and E.coli strains of interest. 
The reasons for the low expression of the mTKIN can be explained through the introduced 
modifications. Most probably the chosen length of the mTKIN stalk domain is the reason for 
the poor expression. A similar finding based on a fungus-deriving kinesin-3 with shorter stalk 
region, without the FHA and PH domains, was  reported (Adio et al. 2006). Kinesins could 
possess potentially toxic properties in prokaryotic organisms. For sure, the lack of suitable 
tRNA can not be the reason for low yield of mTKIN, since its sequence has been codon-
optimized. Further, successful expression of multiple Avi-His-tagged proteins points out that 
the Avi-His tag is most likely not hampering the expression yield of mTKIN (Z. Konthur, pers. 
communication) Finally, a rather remote reason for low expression levels could be the choice 
of vector for the expression of mTKIN. Although pQDKG2 is a derivative of a standard 
protein expression vector from Qiagen (pQE30), it might not be suitable for yielding larger 
amounts of the mTKIN. To my knowledge, no other kinesin has been ever reported to be 
expressed in a pQE- or pQE-derived vector. When comparing the expression patterns of 
mTKIN after varying induction time periods and expression temperatures, several differences 
were observed. Firstly, the induced expression of mTKIN at lower temperatures over a longer 
period of time changed the ratio between soluble and the insoluble mTKIN. Expression of 
mTKIN at 37°C for 3 hours produced more insoluble than soluble mTKIN, whereas 
expression at 22° C for 5 hours or 18°C for 18 hours yielded almost the same amounts of 
both soluble and insoluble mTKIN. Over all, larger amounts of mTKIN were produced at 
lower temperatures and longer time periods. It might be possible that certain kinesins are 
more toxic for E. coli cells than others due to a higher intrinsic ATPase activity. In such a 
case, expression of large amounts of mTKIN could lead to accumulation of larger quantities 
of mTKIN within single cells. This in turn might lead to recruitment of a defense mechanism 
which keeps the soluble mTKIN below a certain concentration by depositing the excess 
quantities in inclusion bodies. During a prolonged period of induction under lower 
temperature the expression of mTKIN within individual cells might be low. Furthermore this 
might not lead to overloading of the host cell folding machinery. Culturing at these conditions 
(18° C for 18 h) produce more biomass and overall similar amounts of mTKIN are expressed 
as other expression conditions (37° C for 3h), while keeping the ratio in favor of the soluble 
mTKIN. Next to higher yield of soluble protein, another positive aspect was observed in 
respect of degradation products. Since the Avi-His6-tag is positioned on the C-terminus of 
mTKIN, only N-terminal degradation products can be detected on Western blots. In this 
respect, the lowered temperature and prolonged induction time gave again better results, as 
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reduced numbers and amounts of N-terminal degradation products relative to the other 
expression conditions were produced. The reduction of degradation product can be observed 
more clearly form the anti-His detection where 2-3 degradation products are found when 
expressing at 37°C for 3 hours and just one detectable degradation product is seen from the 
expression of mTKIN at 18°C and 18 hours. The reasons for this are most probably the same 
as for the ratio shift between soluble and insoluble mTKIN. So it might be possible that larger 
quantities of mTKIN per cell are being degraded more excessively. This concludes that 
optimal mTKIN expression can be achieved by induction at 18° C for 18 hours. 
In order to investigate if mTKIN expression can be further improved in regard to larger 
quantities of soluble protein and reduced production of degradation product, the expression 
of mTKIN was tested using in total four different E. coli expression strains. BL21 (DE3) Star 
pRARE3 was used as it is the strain established in the laboratory of Dr. Zoltán Konthur for 
the production of biotinylated recombinant proteins. Two other strains were chosen because 
their use to express kinesins successfully has been reported. BL21 CodonPlus (DE3)-RIL 
has been used to express kinesin-3 from Neurospora crassa and BL21 (DE3) pLysS has 
been used to express recombinant kinesin of Drosophila melanogaster (Berliner et al. 1994). 
The last strain used for the expression screening was Origami B (DE3) pLacI, which 
possesses the properties of the Tuner (DE3) pLacI strain that has been used for the 
recombinant expression of the wild-type TKIN from Themomyces lanuginosus (Rivera et al. 
2007). The results of the screen showed that all four strains are expressing similar amounts 
of soluble mTKIN, however, different amounts of d3egradation products were observed. 
Strain BL21 (DE3) pLysS, produced three N-terminal degradation products whereas the 
other three strains produced only one (Figure 3-2). The BL21 (DE3) Star pRARE3 produced 
only one detectable degradation product of mTKIN, however the amounts of the mTKIN 
degradation product produced by this strain were larger than those produced by BL21 
CodonPlus (DE3)-RIL and Origami B (DE3) pLacI. Strains BL21 CodonPlus (DE3)-RIL and 
Origami B (DE3) pLacI gave the best results. Notably, strain BL21 CodonPlus (DE3)-RIL 
grew faster and showed less batch to batch variation than Origami B (DE3) pLacI strain 
which was more difficult to cultivate. The mTKIN used for purification and further 
characterization in this investigation was produced using either the BL21 CodonPlus (DE3)-
RIL or the Origami B (DE3) pLacI strain. The presence of mTKIN C-terminal degradation 
products is not relevant, since mTKIN was subsequently purified using Ni-NTA affinity 
chromatography. All C-terminal degradation products should not bind the matrix as they are 
missing the C-terminal Avi-His6-tag and thus are being washed away. Another important 
feature of mTKIN expression is its potential of being biotinylated. Since biotin forms a strong 
interaction with streptavidin, biotinylation of mTKIN enables it directly to interact either with 
streptavidin-functionalized surface or streptavidin conjugated proteins. From the Western blot 
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analyses it becomes evident (Figure 3-1) that mTKIN was very efficiently biotinylated in all of 
E. coli strains under investigation, even though an earlier investigation on the production of a 
biotinylated kinesin (Berliner et al. 1994). However, in that report not the AVI-tag was used, 
but a larger biotinylation acceptor site derived from the biotin carrier complex protein (BCCP). 
4.2 In vitro expression of mTKIN 
As an alternative to in vivo expression in E. coli, the possibility to express mTKIN in vitro was 
investigated using a commercially available in vitro expression kit. From the Western blot 
analysis (Figure 3-3) of the in vitro expressed mTKIN purified with Ni-NTA magnetic beads 
purified, we can see that mTKIN was successfully produced using not unpurified mRNA 
template in the reaction. The absence of an expression product in the in vitro translation 
reaction after mRNA purification could be due to a massive RNA loss during the purification 
step, or a RNase contamination. The unsuccessful attempt to further purify the in vitro 
produced mTKIN with on ATP-agarose can be interpreted in multiple directions. One is that 
the in vitro produced mTKIN failed to fold properly and, hence, did not bind to the EDA-ATP-
agarose. Another possibility is that only a small proportion of the produced mTKIN folded 
properly and since the initial concentration of mTKIN in the translation reaction was already 
very low, the concentration of ,mTKIN in the elution fractions after EDA-ATP-agarose 
purification was simply below the detection limit. Because of time and financial restrictions, 
the expression of mTKIN was not further investigated using in vitro expression systems. In 
principle, if any in vitro expression system would succeed to produce larger quantities of 
functional mTKIN, its application in nanobiotechnology and nanotechnology could be of high 
interest. 
4.3 Developing a two-stage purification procedure for kinesins 
Following the logic of using easy, fast and cost-effective means of producing purified mTKIN 
a novel Ni-NTA agarose and subsequent ATP-agarose affinity purification procedure was 
established. The first part of this two step purification procedure included a standard and 
routinely applied Ni-NTA affinity purification procedure of His6-tagged proteins. This 
purification procedure is fast, inexpensive and in its simplest form it is composed of batch 
hybridization of the target protein followed by washing and elution applying gravity flow using 
a polypropylene column. As a direct consequence, only small amounts of reagents and 
buffers are consumed per run and, if stored properly, the Ni-NTA agarose can be reused 
several times. However, this procedure is principally suited for one step purification only 
when the recombinant protein is being expressed in large quantities. This was not the case 
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for mTKIN as many other proteins were co-eluted from the matrix (Figure 3-5). Although a 
range of unspecific proteins were co-purified with mTKIN, a depletion of the mTKIN in the 
flow-through fraction was demonstrated. This was concluded from Western blot analyses of 
the purification fractions (Figure 3-5). Since mTKIN possesses a AVI and a His6-tag, all 
following Western blot analyses were performed with streptavidin-HRP so that the biotin-
tagged mTKIN could be identified among the other Ni-NTA-co-purified proteins. The number 
of proteins which can be purified with Ni-NTA agarose and that can be detected with an anti-
His6 antibody differ substantially. This is due to the difference in the interaction mechanism 
of the hexahistidine polypeptide. The anti-His6 antibody is very specific for His6-tagged 
proteins. However, if a protein has less than six histidines at any terminal, the antibody will 
most probably not bind or – in best case – just weakly bind to the protein. On the other hand 
Ni-NTA will undergo an interaction with two closely positioned histidines (Figure 4-1) and 
theoretically a His6-tagged protein can be immobilized by three Ni-NTA complexes. However, 
if other proteins have two neighboring histidines spatially accessible for the Ni-NTA ,or two 
histidines which are positioned in a very close proximity through structural conformation and 
are spatially accessible for the Ni-NTA at the same time, they will most probably also be 
bound. Hence other unspecific proteins can be co-purified with the His6-tagged protein if its 
concentration is low and many free valences of the Ni2+ ions remain available. Furthermore, 
in cases where not all six histidines are accessible, the His6-tagged protein could be partially 
or completely eluted while trying to wash away unspecific proteins with higher imidazole 
concentrations. 
 
Figure 4-1: Schematic representation of how two histidines from a poly-histidine-tag interact 
with Ni-NTA taken from :http://www.biologie.uni-osnabrueck.de/Biophysik/Piehler/ 
grafik/research_figure4new.jpg 
Like all other kinesins, mTKIN possess an ATP binding pocket and ATPase activity. This 
characteristics was exploited in a second chromatography step to purify mTKIN on ATP-
functionalized agarose. To my knowledge the purification of kinesin on ATP-agarose has not 
been shown previously. ATP-affinity chromatography was used to further purify mTKIN from 
the unspecific Ni-NTA co-purified proteins. Since it is expected that only properly folded 
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mTKIN to possess a functionally folded ATP-binding pocket capable of binding to ATP-
agarose, all misfolded mTKIN would be removed in the flow-through or washing fractions 
together with the unspecific proteins. Additionally, the N-terminal proximity of the ATP-
binding pocket prevents most N-terminal degradation products to bind ATP. Thus, these 
proteins will also be removed efficiently. Hence, with this two-stage protocol it should be 
generally possible to specifically purify only functional kinesin. The results observed from the 
Coomassie stained SDS-PAGE demonstrated this nicely as only full-length mTKIN was 
enriched in the elution fraction and depleted in the flow-through fraction (Figure 3-6). 
Furthermore, from Western blot analyses it could be observed that N-terminal degradation 
products were detected primarily in the flow-through are were hardly present in the elution 
fractions. The only N-terminal degradation product which was detectable in the elution 
fraction after purification was a product right below the full length mTKIN which otherwise 
were not detectable, possibly because it is normally present only in quantities below the 
detection level of Streptavidin-HRP. It can be argued, that this fragment is probably a N-
terminal degradation fragment only missing a few N-terminal residues, thus neither 
compromising the ATP-binding pocket, nor hampering ATP binding activity. Thus, it might 
well be fully functional. Another important feature in establishing an ATP-agarose mediated 
mTKIN purification procedure is the possibility to determine the way ATP is being bound by 
mTKIN. This is possible because there are four different ways ATP can be coupled onto the 
agarose (Figure 2-3). As no prior information was available, a purification screening was set 
up to test all four types of ATP-agarose and by analyzing the flow-through and elution 
fractions by SDS-PAGE and Western blot, the screen could identify which of the ATP-
agaroses is most suitable for purification (Figure 3-6). EDA-ATP agarose suites best to purify 
mTKIN efficiently. The failure to enrich mTKIN with AP-ATP-agarose indicates that the γ-
phosphate is most probably being held by a residue positioned inside the ATP pocket where 
it can be hydrolytically separated from the ATP. Furthermore, mTKIN was neither enriched 
with 6AH-ATP agarose nor 8AH-ATP-agarose (Figure 2-3). This implies that adenine is very 
specifically recognized by the ATP-binding pocket, suggesting that other purine nucleotides 
like GTP can not be used as substrate by mTKIN. Bearing in mind that the purpose of ATP-
affinity-chromatography was to obtain functionally active kinesin molecules, the 
manufacturers recommendations for buffer supplements was significantly amended. Firstly, 
DTT was omitted from the wash and elution buffers, since mTKIN is cysteine-free and hence 
can not build disulfide bonds, which could lead to missfolding of a protein in absence of DTT. 
Moreover, the successful purification of mTKIN with EDA-ATP-agarose demonstrates that 
folding of mTKIN was most probably not affected by the exchange of cysteine residues 
present in the wildtype TKIN. Secondly, sodium-orthovanadate was also omitted from the 
binding, wash and elution buffer. The intended function of sodium-orthovanadate is to protect 
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the hydrolysis of the functionalized ATP on the agarose by ATPases found in a crude protein 
extract, as it is an ATPase-inhibitor. In this case mTKIN was previously Ni-NTA-purified so it 
was unlikely that other ATPases were present in the used mTKIN containing sample. A more 
important reason of avoiding sodium-orthovanadate has been previously reported. 
Orthovanadate occupies the γ-phosphate position in the ATP binding pocket of myosin, 
another motor protein, and impairs the release of ADP, thus stalling the function of myosin 
(Rayment 1996). This would have meant that mTKIN would have been rendered inactive by 
sodium-orthovanadate during the purification process if added. Third and final remark on the 
purification procedure is the inefficiency of the batch purification method in itself. The fact 
that the ATP-affinity chromatography was carried out in batch where the ATP-agarose is 
collected by centrifugation and the supernatant collected by a pipette, makes it possible for 
other proteins to remain in the elution. The proteins can be either held by the ATP-agarose or 
are simply not being diluted sufficiently during the washing, as the wash buffer of the ATP-
agarose void volume can not be collected by a pipette. This is reflected in the Coomassie 
stain and Western blot analyses of the fractions, where small amounts of unspecific proteins 
detectable in the flow-through are being carried on in the elution fraction in all four types of 
ATP-agaroses. Adapting the approach to gravity-flow column was unfortunately not possible 
due to the small amounts of ATP-agarose used in this purification screening. In order to 
avoid this contamination larger amounts of ATP-agarose should be used, which after the 
batch hybridization can be washed and eluted in a column by gravity-flow. Nevertheless the 
results show that this novel two-stage approach for purification of mTKIN was successful. 
Apart from the almost exclusive purification of full-length, properly folded mTKIN it also 
provides information if some of the performed sequence modifications effect the folding and 
function of the mTKIN. In conclusion, this two step purification method should be with no 
doubt applicable for other His6-tagged kinesins. It would be, however, interesting to 
investigate whether other kinesins will also only bind to the EDA-ATP-agarose. This way it 
could be determined how conserved the functional structure of the kinesin ATP-binding 
pocket is. 
 
4.4 Adapting the two-staged purification procedure to FPLC-systems 
Binding of unspecific proteins to Ni-NTA-agarose demonstrated that mTKIN can not be 
purified sufficiently using the batch/gravity-flow procedure. An alternative to increase the 
efficiency of Ni-NTA affinity purification is the use of a FPLC system. The initial Ni-NTA 
affinity FPLC run was performed with a long linear gradient and resulted in a peak fraction 
containing five proteins detectable by Coomassie stain after SDS-PAGE. A Western blot 
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analysis hybridizing streptavidin-HRP confirmed that the ~60 kD protein band corresponds to 
biotinylated mTKIN. However, the peak in the chromatogram was rather formed by two larger 
proteins. From the analyses by Western blot and Coomassie stained SDS-PAGE (data not 
shown) it became evident that mTKIN was eluted almost in the same range as the two 
proteins larger in size, but its peak elution fraction was at higher imidazole concentration. To 
assess, whether this shifted elution peak on the chromatogram generally apply to Avi-His6-
tagged proteins, another Ni-NTA FPLC chromatography run of an Avi-His6-tagged ubiquitin 
precursor protein (Ubi8) was performed using the same gradient. The elution peak of Ubi8 
matched the expectation, that Avi-His6-tagged proteins produce a peak at a slightly higher 
imidazole concentrations than the other unspecific proteins (Figure 3-7). For this reason a 
custom gradient for the purification of the relatively small amounts of mTKIN was produced. 
This included a linear gradient starting from the wash buffer imidazole concentration up to 
the imidazole concentration where the Avi-His6-tagged proteins were starting to be eluted in 
order to deplete unspecific proteins as much as possible without loosing the mTKIN. This 
was followed by an isocratic step of imidazole concentration where the elution peak of 
mTKIN was expected. Finally another isocratic step was added at maximum imidazole 
concentration to elute any remaining proteins (Figure 3-8). This method resulted in earlier 
depletion of unspecific proteins and hence improved the protein composition of the elution 
containing fractions just a little in favor of mTKIN. The Ni-NTA FPLC run with the same 
custom gradient using soluble protein extract from 200 mL cultures of mTKIN expressed in 
BL 21 CodonPlus (DE3)-RIL and Origami B (DE3) pLacI surprisingly discovered further 
differences between the expression pattern of these two strains. The Coomassie stained 
SDS-PAGE analysis of the elution fractions from the two purifications pointed out that 
although the same five proteins were observed in both sets of elution fractions, the sample 
derived from the Origami B (DE3) pLacI strain produced smaller amounts of the two larger 
proteins. At the same time larger amounts of mTKIN relative to the amounts purified from the 
BL 21 CodonPlus (DE3)-RIL strain was produced (Figure 3-9). The two significantly smaller 
proteins which were shown to be consistently co-purified, were found in roughly the same 
concentrations in both strains. Western blot analysis of the same fractions revealed that none 
of the four observed unspecific proteins is an Avi-His6-tagged protein or a mTKIN N-terminal 
degradation product. Nevertheless the Western blot surprisingly discovered that the two 
strains were producing different N-terminal degradation products (Figure 3-10). This can be 
explained through the difference in the culture volume and the buffer changes during the 
purification procedure. BL 21 CodonPlus (DE3)-RIL produced two N-terminal degradation 
products smaller in size, but in larger quantities than the single degradation product 
produced by Origami B (DE3) pLacI. This results pointed out that the Origami B (DE3) pLacI 
was the best strain for mTKIN expression, although it needs more time to grow to the optimal 
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cell density for expression and is generally more difficult to cultivate in comparison to the 
BL21 CodonPlus (DE3)-RIL. To further increase the effect of the shifted elution peak the 
mTKIN containing fractions from a Ni-NTA FPLC run were pooled, diluted 1:2 with NPI-10 in 
order to lower the imidazole concentration and used this as a loading sample in a second 
identical Ni-NTA affinity FPLC run. This was expected to further deplete the unspecific 
proteins and resulted in the removal of the two larger proteins from the mTKIN elution-
fractions, while one of the smaller unspecific proteins still co-purified with mTKIN (Figure 
3-11). To better understand this situation, mTKIN and the four unspecific proteins detected 
on the SDS-PAA gel were analyzed using mass spectrometry in order to investigate if the 
other four proteins (1, 2, 4 and 5 form Figure 3-9) are in any way linked with mTKIN (band 3 
from Figure 3-9). The results discovered that all four unspecific proteins were actually 
endogenous proteins from E. coli. However, the protein corresponding to band 4 is a 
chaperone (PPI) and was eluted at the same imidazole concentrations as mTKIN. This 
suggests that PPI might be bound to mTKIN and not to the Ni-NTA agarose. However, this 
protein can not be detected by Coomassie stain in the elution fractions obtained from EDA-
ATP-agarose purification (Figure 3-6). If the assumption is correct that PPI binds mTKIN, a 
possible explanation for this might be that PPI disassociates from mTKIN in presence of ATP, 
This would also mean that ATP stabilizes the correct mTKIN conformation. To test this 
hypothesis a Ni-NTA FPLC should be performed using buffers which contain 1 mM ATP. If 
under these conditions PPI is not detectable any more by Coomassie stain in the mTKIN-
containing elution fractions, this hypothesis will be proved. Another important aspect of the 
mass spectrometric data is the identification of 7 peptides from the mTKIN which share 
characteristics for 12 other KIF1/Unc104 kinesins. This confirms the high degree of 
homology between mTKIN and the kinesin-3 family. In the course of adapting the two-stage 
purification for FPLC systems a cartridge was assembled by loading with 250-300 µL bed 
volume of EDA-ATP agarose that has been already used in batch purification. In a first 
attempt, the cartridge was loaded with mTKIN-containing sample. The isocratic elution with 1 
mM ATP resulted in steady elution of equal mTKIN amounts throughout the elution fractions 
(data not shown). These amounts of mTKIN produced only faint signals on a Western blot. 
One possible reason for continuous mTKIN elution over time could be that 1mM ATP elutes 
only small amounts of mTKIN, as it might correspond to a start of a elution peak. This could 
be tested by repeating the purification run under the same conditions with 2-3 fold higher 
ATP concentration during elution. The second reason for this elution behaviour could be the 
fact that in contrast to Ni-NTA, where the binding of the His6 tag is being competed by the 
imidazole which has a higher affinity for the Ni-NTA, the ATP-agarose purification follows a 
different mechanism. In this case the binding of the protein to the ATP-agarose is not being 
competed away by the ATP in the elution, but rather lies on the continuous association and 
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disassociation of the ATP from the mTKIN’s ATP-binding pocket. Higher concentrations of 
ATP during elution would then not effect the dissociation, but rather circumvent re-
association of released mTKIN. So the elution of the mTKIN would be a function of time 
rather than ATP concentration. To test the time dependent manner of mTKIN elution from the 
ATP-agarose, the FPLC purification was repeated including two 20-minute pauses after the 
column was flooded with elution buffer. The fraction containing the elution directly after the 
first pause contained enough mTKIN to be detectable by Coomassie stain after SDS-PAGE. 
The fraction containing the elution after the second pause contained less mTKIN, which was 
only detectable using Western blot (Figure 3-12). This confirmed that larger amounts of 
mTKIN can be eluted as a function of time. Due to time restrains the elution with higher ATP 
concentrations was not performed, so it is still not clear if mTKIN can form a peak by elution 
with higher ATP-concentrations. For the optimal investigation of this open question, the 
FPLC purification should be performed using the 1 mL EDA-ATP-toyoperl column offered 
from the same manufacturer as the ATP-agarose. This column has a tightly packed matrix 
making it is suitable for experimenting with different gradients. As of now, the optimal 
purification of large amounts pure, properly folded and functional mTKIN would contain two 
stages. First, a Ni-NTA affinity purification on a FPLC systems using the customized gradient 
would be performed. In a second step, pooled mTKIN containing elution fractions of the first 
purification step would be used for batch/gravity flow purification with the EDA-ATP-agarose. 
4.5 Periplasmic expression and phage display of mTKIN 
For all experiment described in this section the pIT2/mTKIN construct was used. This 
construct allows either the expressed mTKIN to be translocated to the periplasm, or the 
presentation of mTKIN as a pIII-fusion on the surface of M13 bacteriophage. Depending 
whether mTKIN is targeted to the periplasm or to the phage surface, either the non-
suppressor E. coli strain HB2151, or the suppressor strains TG1 and XL1-blue were used for 
expression. Switching between these two types of expression is possible because the vector 
construct is generated in such a way that an amber stop is encoded between the mTKIN and 
pIII molecule. Furthermore, mTKIN is expressed together with the pelB leader sequence at 
its N-terminus. First periplasmic expression of mTKIN was investigated. One reason for this 
was to assess whether mTKIN could be produced in the periplasm in larger amounts than in 
the cytoplasm. This might be advantageous, as the presence of the pelB leader sequence 
would cause the mTKIN to be translocated to the periplasm in an unfolded state over the Sec 
pathway where it could then refold in its functional state (Nilsson et al. 1991). mTKIN was 
expressed according to two different protocols in E. coli strain HB2151. Next, protein 
samples from periplasmic preparation and spheroblasts were analyzed for mTKIN 
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expression in a Western blot by detection with an anti-His-antibody (Figure 3-4) The results 
suggest, that mTKIN is only expressed in the spheroblasts irrespective of the preparation 
protocol and translocation of the mTKIN to the periplasm does not occur. However, this can 
not be interpreted as a proof that there is no mTKIN in the periplasm, because it could be 
highly diluted by the relatively large volume of the periplasm preparation. The fact that 
mTKIN was detectable in the spheroblast confirms that mTKIN is overall expressible in E. 
coli HB2151 cells. To present mTKIN on the surface of phage particles, mTKIN-pIII fusion 
was expressed in TG1 and XL1-blue cells. Phage production in these cells is possible after 
superinfection with helper phages, M13KO7 and Hyperphage. Former allows monovalent 
display and latter allows multivalent display of mTKIN on the phage particle. First, all four 
combinations of host and helper phages were used to prepare phage particles. From the 
western blot analysis of the four different types of phages (Figure 3-14) it was seen that 
mTKIN was successfully displayed as a pIII fusion protein on phages produced in both 
strains. Notably,this also confirms the ability to translocate mTKIN to the periplasm, as this is 
a prerequisite for presentation of mTKIN on the phage surface. As expected, the amount of 
mTKIN-pIII fusion detected on the Western blot was higher when superinfection was done 
with hyperphage allowing for multivalent display The absence of detectable mTKIN-pIII 
fusion on the phage particles prepared with hyperphages produced in TG 1 host strain is 
explainable through the titration values (Table 3-1). These phage suspensions is 100-times 
less concentrated than the ones produced in XL-1 Blue host strain with the same helper 
phage. From the western blot analysis also the phenotypical difference between the phage 
populations generated by M13KO7 or hyperphage superinfection can be seen. The phage 
particles made with M13KO7 usually carry only one pIII fusion protein and the remaining four 
are wild-type pIII proteins. This is reflected on the western blot, as large amounts of pIII are 
detected in the corresponding phage populations and just a small portion of mTKIN-pIII 
fusion protein is available. On the other hand the phage particles generated with hyperphage 
are constructed in such way that only the pIII fusion protein, in this case the mTKIN-pIII, is 
being expressed. So all five copies of pIII needed for the phage assembly are fusion proteins 
(Rondot et al. 2001). This superior presentation efficiency of mTKIN-pIII fusion protein comes 
with a prize on the overall yield of phage particles. From the titration it can be seen that 
irrespective of the host strain around 102-103 times less phage particles are generated by 
hyperphage superinfection in comparison to the M13KO7 superinfection. The presentation 
efficiency of M13KO7 helper phage derived phage population is known to be around 1-10% 
(Rhyner et al. 2003), hat is 1-10% of phage particles carry a mTKIN-pIII fusion protein on its 
surface. Bearing this and the reduced yield of phage particles produced with hyperphages in 
mind, the overall number of presenting phage particle in both populations is more 
comparable. The difference is primarily found in the number of mTKIN molecules fusion 
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presented on an individual phage. This can be of interes in future applications, as kinesin 
molecules are homodimers and dimerisation is a prerequisite of efficient transport. These 
correlations are important for a later study and attempts to use the phages for selection. Also 
from the titration values we can observe that irrespective of the helper phage the XL-1 Blue 
host strain produces 102 times more phages than the TG 1 host strain. This points out that 
the XL-1 Blue host strain will be most probably used for production of mTKIN presenting 
phages in the future. The ability of mTKIN presenting phages to bind to MTs was tested by a 
phage ELISA. However, coating of the microtiterplate wells with MTs failed and no signals 
could be recorded. Immobilistion of MTs, for instance indirectly with anti-tubulin antibody 
studies should be optimized in the future, before this ELISA can be repeated. 
4.6 NADH oxidation coupled double enzyme ATPase assay 
For transporting microtubules kinesins require energy which they obtain from consumption of 
ATP. Hence measurement of ATPase activity with and without the addition of MTs is a clear 
indicator for the functionality of kinesins. For this purpose, a NADH oxidation coupled double 
enzyme ATPase assay in microtitre plate format was established. It allows to determine 
kinetic data of ATPase activity by measuring the change of light absorption at 340nm using a 
microtitre plate reader. The produced data for mTKIN as well as a positive control kinesin 
construct (KIF1A-GFP) was very precise and the need of less amounts of reagent meant that  
larger number of measurements could be performed. The advantage of this ATPase assay is 
that the double enzymatic system quickly replenishes the hydrolyzed ATP, thus simulating a 
reaction at constant substrate concentration. This is important for the evaluation, because 
the rate of the reaction is not being affected by the usually changing substrate concentration 
and is therefore held at the starting rate of ATP hydrolysis. The second advantage of this 
system is the 1:1 stoichiometry of the hydrolyzed ATP to oxidized NADH. With help of the 
specific extinction coefficient for NADH at 340 nm and the length of the light path through the 
solution the concentration of NADH, or in this case the change in NADH concentration, can 
be calculated in accordance with the Lambert-Beer law. With this, the initial rate of ATP 
hydrolysis at a given concentration can be observed. These features made it possible to 
measure a steady rate of hydrolysis over longer periods of times. In most cases the fit of the 





Figure 4-2: A representative series of absorption measurements at 340 nm from a single well 
containing mTKIN, MTs and 2 mM ATP with a fitted linear regression. Generated 
using SoftMax Pro software. 
The measured changes of the ATP hydrolysis rates by different ATP concentrations for 
KIF1A-GFP and mTKIN displayed typical Michaelis–Menten kinetics (Figure 3-16). The 
evaluated Vmax and Km values for the intrinsic ATPase activity of the KIF1A-GFP and mTKIN 
were very similar. However in presence of 1 mM MTs, which is well over the reported MT 
concentration required for half-maximal velocity measured for wild-type TKIN (Rivera et al. 
2007), the ATP hydrolysis rates increased for both kinesins under evaluation. Regarding the 
maximal ATP hydrolysis rate, this was more dramatic for the mTKIN (4.3-fold) than for the 
KIF1A-GFP (2.2-fold). This is a clear biochemical evidence that mTKIN interacts with MTs, 
which causes a strong increase of its ATPase activity. This feature is characteristic for 
kinesins as it can also be observed in the case of the positive control (KIF1A-GFP). The Km 
values for the ATPase activity of the mTKIN in presence 202.5 ± 32.67 µM and absence of 
MTs 238.3 ± 39.19 µM are overlapping when observed within their statistical error. Also 
these Km values which were calculated from measurements taken at ~30° C fit between the 
two Km values 42 ± 6.8 µM and 1600 ± 300 µM for the ATPase activity of the wild-type TKIN 
measured at 25° C and 50° C, respectively (Rivera et al. 2007). Hence confirming the rise of 
the TKIN’s Km value with rising temperatures. The ATP turnover of mTKIN in presence of 
MTs (~10,6 s-1) is very similar to the one reported for TLKIF1 (~8 s-1), another isoform of the 
T. lanuginosus kinesin-3 (Sakowicz et al. 1999) Unfortunately the basal ATP turnover rate of 
TLKIF1 and the ATP turnover rates in presence and absence of MTs for the wild-type TKIN 
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have not been reported. So the rise of the ATP turnover by mTKIN (4.3-fold) upon addition of 
MTs can not be properly compared. Also, these results are not comparable with other 
kinesins. For example the ATP turnover of D. melanogaster-derived kinesin increases 3000-
fold (Huang and Hackney 1994) and in the case of kinesin-3 from N. crassa, which is very 
closely related to mTKIN, the ATP turnover increases around 100-fold upon addition of MTs 
(Adio et al. 2006) Therefore, MTs-mediated rise of ATP turnover is rather variable among 
kinesins and the relatively small increase observed for mTKIN can not be interpreted as an 
effect produced by the introduced modifications. In summary, these results show that the 
conservative substitution of the cysteine residues do not affect the normal biochemical 
properties of mTKIN. This is very important since these modifications play a key role in the 
folding of mTKIN in a functionally active form. This raises the chances that phage-displayed 
mTKIN should also be biochemicaly active. However within the given timeframe of this study 
the ATPase activity of phage displayed kinesisn couldnot be determined using the NADH 
oxidation coupled double enzyme ATPase. So it is of high interest to biochemical 
characterize mTKIN presenting phages with this ATPase assay once new phages will be 
prepared. 
4.7 In vitro motility assay 
The best way to observe and prove the mechanochemical property of kinesins is to moitor  
their movement along microtubules by an in vitro motility assay. One way of performing this 
assay is to coat a microscope slide surface with kinesin and to add fluorescently labeled MTs. 
The fluorescently labeled MTs are well observable under a microscope and directed 
movement (gliding) of MTs above a kinesin coated surface can be observed in presence of 
ATP. This kind of assay was successfully established and movement of ROX-MTs could be 
observed in a simple build flow cell previously incubated with stock solution of KIF1A-GFP. 
This confirmed that the applied procedure for the motility assay is successful. However, 
when mTKIN was used to coat the flow cell and ROX-MTs was added, no movement could 
be observed. More importantly, ROX-MTs did not adhere to the surface which should have 
been coated with the mTKIN as was the case with the positive control (Figure 3-17). This 
could be explained through the low mTKIN stock concentration at hand. The concentration of 
the KIF1A-GFP stock solution was ~10 times higher than the total protein concentration of 
the Ni-NTA affinity FPLC purified mTKIN (around 170 µg/mL). The use of ATP-agarose 
purified mTKIN was not considered, since its concentration was per se lower than that of the 
previously used mTKIN fraction. The use of such low protein concentrations (under 100 
µg/mL) have been also reported for the wild-type TKIN as marginal for observing kinesin 
driven MTs movement was 100 µg/mL (Rivera et al. 2007). However the actual surface 
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density of kinesin can not be determined from the solution concentration of the protein. For 
this reason several mTKIN fractions were pooled and concentrated to a total protein 
concentration of around 300 µg/mL of mixed protein population. The adherence of the ROX-
MTs to the supposedly mTKIN coated surface was still very weak. Interestingly, truncating of 
the ROX-MTs was observed in this attempt. This can be interpreted as a result of a 
functional interaction with mTKIN, but as it was rarely reproducible it might well be a 
technical artifact. The failure to observe a mTKIN-driven ROX-MT-movement are most 
probably caused by the relatively low partial concentration of mTKIN in the used fractions. 
Another potential problem could be that unspecific proteins resulting from the purification 
process might populate the surface. The coating of the surface with other proteins could lead 
to an even lower surface density of mTKIN or even preventing it to adhere to the surface 
completely as the other proteins might possess more “sticky” properties towards the glass 
surface. Also the attempt to observe MTs movement by enriched mTKIN onto a streptavidin 
coated surface was unfruitful. In this case the mTKIN might have been spread evenly all over 
the surface without the possibility for eventual clustering which would improve the adherence 
and movement of the MTs. However the few observed ROX-MTs which adhered to the 
surface were immobile. Hence it is still not proven that mTKIN is mechanochemicaly inactive. 
The observed MTs might have simply stalled similarly to the many stalled ROX-MTs in the 
positive control assay after being directionally moved by the KIF1A-GFP. There are two ways 
to overcome this problem. Either much larger quantities and more concentrated samples of 
pure mTKIN need to be produced, or an alternative approach of the motility assay need to be 
performed. This could be for instance done by inverting the transportation mode. In this case, 
the fluorescently labeled MTs would be first functionalized onto a slide surface, most 
probably by using anti-tubulin antibodies. Then, in order to overcome the molecule density 
problem, small (< 2 µm Ø) streptavidin-coated fluorescent beads or quantum dots would be 
functionalized with biotin tagged mTKIN (Shishido et al. 2010) Finally, the mTKIN loaded 
beads would be added to the MT-coated flow cell and their movement along the MTs would 
be observed. Due to temporal restrains the inverted motility assay could not be performed. . 
Similarly this approach might be applicable for the investigation of the mechanochemical 
properties of phage-displayed mTKIN. As multiple kinesins are presented at one end of the 
phage particle, the local concentration of kinesins could be strong enough to drag the whole 
phage particle along microtubule tracks. So it might be possible to observe phages moving 
along MTs, if the phage capsid would be decorated with fluorescently-labeled antibodies. 
4.8 Future prospects 
Within this study mTKIN expression and purification schemes were established. Furthermore, 
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the ATPase activity of mTKIN was successfully determined and an in vitro motility assay was 
set up. The next steps to be conducted would be to express larger quantities of mTKIN and 
to repeat the motility assay with higher concentrations of mTKIN. In parallel, it should 
determined whether mTKIN produces dimers. This can be tested in two ways, either by 
native PAA gel electrophoresis or by size exclusion chromatography using a column, such as 
a Superdex 200. The second approach would be more precise and the collected fractions 
could be further analysed using SDS-PAGE and Western blot. In case mTKIN dimerises, a 
protein peak at around 110 kD should be detected, which should result in single band on an 
SDA-PAA gel corresponding to 55 kD in size. Size exclusion chromatographic investigation 
of wild-type full-length TKIN showed no presence of dimers (Rivera et al. 2007). However, 
since mTKIN contains only the first CC1 domain, the situation might be different and might 
lead to dimerization. This is plausible since it has been reported that NcKin3, which 
possesses a short stalk without the FHA and PH domains, does form dimers (Adio et al. 
2006). Another important characteristic of mTKIN to be investigated would be the 
measurement of the force it produces while gliding along MTs by hybridization onto 
streptavidin coated beads and using optical tweezers for manipulation as described in Figure 
4-3. 
 
Figure 4-3: Picture of the basic principle how the force of a kinesin is being measured using 
optical tweezers, picture taken from: http://www.sciencedaily.com/images 
/2009/08/090814100101-large.jpg 
A final investigation would be testing the thermostability of the mTKIN as well as the loss of 
activity at different storage temperatures and time periods. This would show how robust the 





Advancement in technology had made it possible to perform high throughput investigations 
by processing many samples at the same time. This massive parallelization of experiments 
and samples was achieved with the use of pipetting robots. Meanwhile, the next step to 
further increase the number of processed samples is the miniaturization of these processes. 
Today, there are already commercially available lab-on-chip applications based on 
microfluidic systems for some simple, routinely used laboratory methods in molecular biology. 
For future development of the lab-on-chip concept and other nanotechnological application 
an active transporting system, such as the kinesin-microtubules system available in nature, 
could offer larger system flexibility. In this study the sequence of kinesin-3 (TKIN), a motor 
protein from the thermophylic fungi Thermomyces lanuginosus (Rivera et al. 2007) was 
modified in different ways, even amenable to phage display. The goal was to test if this 
modified kinesin (mTKIN) is more suitable for nanotechnological use than other kinesins due 
to its thermostability. The possible display of mTKIN on phages in a functional form should 
open up novel possibilities for the selection and production of custom kinesins.  
First, an expression screening in different E. coli strains applying different conditions was 
conducted which showed that optimal expression of the mTKIN is possible in the Origami B 
(DE3) pLacI strain. This strain produces the largest amount of full-length mTKIN and the 
smallest number and amounts of N-terminal degradation products by induced expression at 
18°C for 18 hours. mTKIN was than successfully purified with a novel two stage affinity 
chromatography protocol, first using Ni-NTA and then EDA-ATP-agarose. The second step 
enabled purification only of properly folded mTKIN. Furthermore, purification of mTKIN on a 
FPLC-system showed better results than batch/gravity flow procedure, which however was 
still not comparable to a purification combined with EDA-ATP-agarose. The presentation of 
mTKIN as a pIII fusion protein on phages using two different host strains and two different 
helper phages was successful. The titration values of phages discovered that the obtained 
presentation rates should be suitable for performing selections. Finally a NADH oxidation 
coupled enzymatic assay was used to test for ATPase activity. This showed that mTKIN has 
similar biochemical properties which are comparable with the wild-type TKIN as well as other 
kinesins. A mechanochemical characterization utilizing a motility assay was unfortunately not 
possible due to insufficiency of time. Nevertheless this in vitro motility assay was successfully 
established as directional movement of fluorescent microtubules was observed using another 
kinesin (KIF1A-GFP) as a reference. Further characterization experiments and alternative 
approaches for unsuccessful tests need to be performed in order to better characterize 




Durch fortlaufende technologische Weiterentwicklungen ist es heut zu Tage möglich, 
Hochdurchsatz-Untersuchungen durchzuführen, wodurch eine enorm große Probenmenge 
zeitgleich analysiert werden kann. Die Entwicklung und Nutzung von Pipettier-Robotern hat 
zudem die massive Parallelisierung von Experimenten zugänglich gemacht. Um in Zukunft 
die Anzahl an parallel zu verarbeitenden Proben zu erhöhen, ist der nächste logische Schritt 
die Miniaturisierung des Systems. Einige dieser mikrofluidalen Lab-On-Chip Systeme sind für 
einfache molekularbiologische Untersuchungen mittlerer Weile auf dem Markt käuflich zu 
erwerben. Für die Weiterentwicklung der Lab-On-Chip Systeme sowie weiterer 
nanotechnologischer Anwendungen kann ein aktives Transportsystem, sowie das des in der 
Natur vorkommenden Kinesin-Mikrotubuli Systems, für eine bessere Systemflexibilität 
genutzt werden. Innerhalb dieser Studie wurde die Sequenz des Motor-Proteins Kinesin-3 
aus dem thermophilen Pilz Thermomyces lanuginosus (Rivera et al. 2007) auf verschiedene 
Art und Weise modifiziert, um es unter anderem für das Phage Display System nutzbar zu 
machen. Das Ziel lag darin herauszufinden, ob das modifizierte Kinesin (mTKIN) sich 
aufgrund seiner thermostabilen Eigenschaften für die Verwendung in der Nanotechnologie 
weitaus besser eignet als andere Kinesine und ob es sich auf Phagen in funktioneller Form 
präsentieren lässt. Dies würde letztlich die Selektion sowie die Herstellung von spezifischen 
Kinesinen ermöglichen.Um dies zu erreichen wurde in unterschiedlichen E.coli Stämmen 
sowie unter verschiedenen Bedingungen ein Expressions-Screening durchgeführt. Dabei hat 
sich herausgestellt, das sich der E. coli Stamm Origami B (DE3) pLacI für die Expression von 
mTKIN am besten eignet. Im Vergleich zu anderen Stämmen produziert dieser 
Expressionsstamm bei induzierter Expression bei 18°C innerhalb von 18 Stunden die größte 
Menge an full-length mTKIN und zudem die kleinste Anzahl und geringste Menge an N-
terminalen Degradationsprodukten. Das exprimierte mTKIN konnte schließlich durch eine 
neu entwickelte zweistufige Affinitätschromatographie erfolgreich aufgereinigt werden. Bei 
der ersten Stufe handelt es sich um Ni-NTA-, die zweite Stufe ist EDA-ATP-Agarose. Die 
EDA-ATP-Agarose ermöglicht dabei ausschließlich die Aufreinigung des richtig gefalteten 
mTKIN’s. Des Weiteren konnte mit einer Aufreinigung des mTKIN über Ni-NTA Affinitäts-
FPLC ein besseres Ergebnis erzielt werden als über die Batch/Gravity Flow Methode, wobei 
diese im Vergleich zur EDA-ATP-Agarose eher verunreinigtes mTKIN produziert.  
Das Motor-Protein mTKIN konnte zudem auf vier Phagen-Typen, bestehend aus der 
Kombinatorik zweier unterschiedlichen Wirtsstämmen sowie zweier Helferphagen, als pIII 
Fusionsprotein erfolgreich präsentiert werden. Durch die Phagentitration konnte zudem 
herausgefunden werden, dass sie sich für ein Selektionsverfahren eignen.  
Zu guter Letzt wurde die ATPase Aktivität des mTKIN’s durch einen NADH Oxidations-
gekoppelten doppel-enzymatischen Assay getestet. Dieser hat gezeigt, dass das exprimierte 
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mTKIN über die gleichen biochemischen kinesin-charakteristischen Eigenschaften verfügt 
wie das nicht-modifizierte TKIN. Die mechano-chemische Charakterisierung mittels eines 
Gleit-Assay konnte aufgrund unzureichender Zeit leider nicht durchgeführt werden. Das 
Gleit-Assay konnte dennoch erfolgreich etabliert werden, da eine unidirektionale Bewegung 
von fluoreszenzmarkierten Mikrotubuli beobachtet werden konnte. Diese Bewegung wurde 
durch ein anderes rekombinantes Kinesin (KIF1A-GFP) als Referenz erreicht.  
Um das rekombinante mTKIN sowie das auf den Phagen präsentierte Protein noch besser 
charakterisieren zu können, müssen weitere Experimente und alternative Ansätze für 
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ahpC Mutated alkyl hydroperoxide 
reductase for conferring disulfide 
reductase activity 
 KM Michaelis-Constant 
Ampr Ampicilin resistance  L Liter 
AMPPNP Non-hydrolysable ATP analog  lacIq Lac repressor overexpression 
BCCP Acetyl-CoA carboxylase biotin 
carboxyl carrier proteinsubunit 
 LDH Lactic dehydrogenase 
bimC Tetrameric kinesin  LSCM Laser scanning confocal 
microscope 
bp Base pairs  M Molar concentration (mol/ L) 
° C Degrees Celsius  M13 Filamentous bacteriophage 
CC Coiled coil domain  mA miliAmper 
CCD camera Charge-coupled device camera  MES 2-(N-morpholino) 
ethanesulfonic acid 
CFU Colony Forming Units  MTs Microtubules 
CV Column volume  NADH Nicotinamide adenine 
dinucleotide 
DMSO Dimethylsulfoxid  Ncd D. melanogaster kinesin 14 
DNA Desoxyribonucleic acid  Ni-NTA Nickel nitrilotriacetic acid 
dsDNA Double stranded DNA  ORF Open reading frame 
dNTP Desoxynucleotides  PAA Polyacrylamide 
DTT Dithiothreitol  PBS Phosphate buffered saline 
EDTA Ethylenediaminetetraacetic acid  PCR Polymerase chain rection 
EGTA Ethylene glycol tetraacetic acid  PEG Polyethylen glycol 
EM Electron microscopy  PEP Phosphoenolpyruvic acid 
Abbreviations 
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endA Elimination of endonuclease A  pelB Leader sequence for the Sec 
pathway 




ESI Electrospray ionization  PK Pyruvate kinase 
FHA Forkhead-associated domain  PPI Peptidyl prolyl cis-trans-
isomerase 
FPLC Fast protein liquid chromatography  ROX-MTs X-rhodamine labeled 
microtubules 
g Gram  SDS Sodium dodecyl sulfate 
GF Gravity-flow  SDS-PAGE SDS- Polyacrylamide gel 
electrohporesis 
GFP Green fluorescent protein  Sec pathway Secretory pathway 
gor522 Mutation in glutathione reductase; 
enhances disulphide bond formation 
 SRP Signal recognition particle 
GST Glutathione S-transferase  ssDNA Single stranded DNA 
H2O, bidest. Aqua, water - bidestilated  Tat Twin-arginine translocation 
pathway 
HEPES 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid ) 
 TEMED N,N,N,N-Tetramethyl-
ethylenediamine 
His6 Hexahistidine homopolymer  mTKIN Modified kinesin-3 from T. 
lanuginosus 
HRP Horse reddish peroxidase  TLKIF1 Another iyoform of Kinesin-3 
from T. lanuginosus 
HRP Horse reddish peroxidase  TPR Tetratico peptide repeats 




IPTG Isopropyl-β-D-thiogalactopyranosid  trxB Mutation in thioredoxin 
reductase; enhances 
disulphide bond formation 
KAP Kinesin associated protein  U Units (for enzymes) 
Abbreviations 
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kcat Turnover number  Ubi8 Avi-His6-tagged ubiquitin 
precursor protein 
kD kiloDalton (1 kD =1000 g/mol)  Unc104/KIF1 Kinesin-3 family 
KHC Kinesin heavy chain  UV Ultra-violet light 
KIF1A-GFP Kinesin-3 from R. norvegicus fused 
with GFP 
 V volt 
KLC Kinesin light chain  xg x-fold of mean earth 
gravitational acceleration 
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